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t
I. INTRODUCTION
THE CRIMINAL JUSTICE APPROACH to drug use
and syringe availability has profoundly affected the health of
injection drug users, particularly with regard to infectious dis-
ease transmission. Today, more new cases of HIV are expected
among injection drug users (IDUs) than among any other risk
group in the United States. It has been credibly estimated that
as many as half of all new HIV infections are caused by the
sharing of needles and syringes contaminated with HIV, either
directly due to injection drug use, through sexual contact with
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drug injectors, or by birth to a mother who acquired HIV infec-
tion through one of these means.2 In fact, the sharing of sy-
ringes by IDUs is the leading source of HIV infection among
women and children.3 There is now evidence of a massive epi-
demic of both hepatitis B (HBV) and C (HCV) among injection
drug users.4 Prevalence of HCV among IDUs in the U.S. and
abroad ranges from 65% to 80%.5 The reuse of syringes is also
a known risk factor for acute bacterial endocarditis, subcutane-
ous abscess, and cellulitis. While earlier ethnographic work as-
cribed the sharing of syringes to an IDU culture, research now
shows that sharing is largely the product of the scarcity of sy-
2 See id.; see also Evidence-Based Findings on the Efficacy of Syringe Ex-
change Programs: An Analysis from the Assistant Secretary for Health and Surgeon
General of the Scientific Research Completed Since April 1998 (visited Sept. 30,
2000) <http:llwww.harmreduction.orglissues/surgeongenrev/surgreview.html>.
3 See Pascale M. Wortley & Patricia L. Fleming, AIDS in Women in the
United States: Recent Trends, 278 JAMA 911, 914 (1997); see also PANEL ON
NEEDLE EXCH. & BLEACH DISTRIBUTION PROGRAMS, NAT'L RESEARCH COUNCIL &
INST. OF MED., PREVENTING HIV TRANSMISSION: THE ROLE OF STERILE NEEDLES AND
BLEACH 1, 1 (Jacques Normand et al. eds., 1995) (providing empirical evidence and
recommendations that needle exchange programs offer public health benefits in the
prevention of HIV/AIDS).
4 See Miriam I. Alter & Linda A. Moyer, The Importance of Preventing
Hepatitis C Virus Infection Among Injection Drug Users in the United States, 18 J.
ACQUIR. IMMUNE DEPIC. SYNDR. & HuM. RmROVIROLOGY S6 (Supp. 11998); Harold
S. Margolis et al., Hepatitis B: Evolving Epidemiology and Implications for Control,
11 SEMINARs IN LIVER DISEASE 84, 89 (1991); Miriam J. Alter, The Detection,
Transmission, and Outcome of Hepatitis C Virus Infection, 2 INFEcTIOUS AGENTS &
DISEASE 155, 158 (1993); see also Richard S. Carfein et al., Prevalence and Inci-
dence of Hepatitis C Virus Infection Among Young Adult Injection Drug Users, 18 J.
ACQUIR. IMMUNE DEFIC. SYNDR. & HUM. RETROVIROLOGY S 11, S 11 (Supp. 11998).
5 See, e.g., F. Bortolotti et al., Epidemiological Aspects ofAcute Viral Hepati-
tis in Drug Abusers, 5 INFECTION 277, 278 (1982) (discussing the high prevalence of
non-A and non-B hepatitis among drug abusers); E. Chamot et al., Incidence of
Hepatitis C, Hepatitis B and HIV Infections Among Drug Users in a Metha-
done-Maintenance Programme. 6 AIDS 430,431 (1992) (reporting that in a cohort of
295 IV drug users, 80% were HCV-positive); J.A.R. van den Hock et al., Prevalence,
Incidence, and Risk Factors for Hepatitis C Virus Infection Among Drug Users In
Amsterdam, 162 J. INFECTIOUS DISEASES 823, 825 (1990) (reporting an HCV ser-
prevalance rate of 74%); Jerome B. Zeldis et al., Seroepidemiology of Viral Infections
Among Intravenous Drug Users in Northern California, 156 WJ. MED. 30, 31 (1992)
(finding that 72% of IV drug users in Sacramento were infected with HCV); E.J.C.
van Ameijden et al., A Longitudinal Study on the Incidence and Transmission Pat-
terns of HIV, HBV and HCV Infection Among Drug Users in Amsterdam, 9 EUR. J.
EPIDEMIOLOGY 255, 257 (1993); Ingrid van Beek et al., Risk Factors for Hepatitis C
Virus Infection Among Injecting Drug Users in Sydney, 70 GENITOURINARY MED.
321 (1994).
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ringes.6 Thus, addressing the sharing and reuse of syringes by
IDUs, and the scarcity of syringes that encourages it, is a major
public health priority.
The scarcity of syringes is the direct result of law and law-
enforcement practices. Recent research has found a significant
correlation between HIV prevalence and legal restrictions on
syringe access.7 A web of state syringe prescription, drug para-
phernalia, and pharmacy practice rules restrict the sale and pos-
session of injection equipment and, in effect, make physicians
and pharmacists the gatekeepers to syringe access. Thirteen
states have rules requiring a prescription for a syringe under at
least some circumstances. Other states require the buyer to
demonstrate to the pharmacist a legitimate medical purpose for
the purchase, which makes a prescription useful if not indispen-
sable. Most states have paraphernalia laws that apply to sy-
ringes under at least some circumstances, and which may deter
pharmacists from selling syringes to people they suspect of in-
jecting illegal drugs.
Extensive research shows that providing safe injection
equipment to IDUs prevents HIV and other blood-borne infec-
tions and does not increase drug abuse.8 A recent cost-benefit
analysis indicates that a policy of funding syringe exchange
programs, pharmacy sales, and syringe disposal to cover all il-
licit drug injections would cost an estimated $34,278 per HIV
infection averted, a figure well below the estimated lifetime cost
6 See Stephen K. Koester, Copping. Running, and Paraphernalia Laws: Con-
textual Variables and Needle Risk Behavior Among Injection Drug Users in Denver,
53 Hum. ORG. 287, 287-88 (1994); see also Don C. Des Jarlais & Samuel R. Fried-
man, The Psychology of Preventing AIDS Among Intravenous Drug Users, 43 AM.
PSYCHOLOGIST 865 (1988); Robert S. Broadhead et al., Termination of an Established
Needle-Exchange: A Study of Claims and Their Impact, 46 SOC. PROBS. 48, 61
(1999); Philippe Bourgois, The Moral Economies of Homeless Heroin Addicts: Con-
fronting Ethnography, HIV Risk, and Evetyday Violence in San Francisco Shooting
Encampments, 33 SUBSTANCE ABUSE & MISUSE 2323 (1998).
See S.R. Friedman & D.C. Des Jarlais, Economic Inequality, Poverty, and
Laws Against Syringe Access as Predictors of Metropolitan Area Rates of Drug In-
jection and of HIV. Poster Presentation, Abstract # [WePpE1428], XIII International
AIDS Conference, Durban, South Africa, July 2000 (on file with author).
8 See PANEL ON NEEDLE ExcH. & BLEACH DISTRIBUTION PROGRAMS, supra
note 3, at 2. See generally 1 SCHOOL OF PUB. HEALTH, UNIV. OF CAL., BERKELEY &
INST. FOR HEALTH POL'Y STUD., UNIV. OF CAL., SAN FRANCISCO, THE PUBLIC HEALTH
IMPACT OF NEEDLE EXCHANGE PROGRAMS IN THE UNITED STATES AND ABROAD 347-
61,452-53,467 (1993).
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of medical care for a person with HIV infection. 9 There is now
strong consensus among public health and medical authorities
that IDUs should use sterile equipment for every injection.' 0
The leading federal public health agencies addressing drug use
prepared a set of consensus guidelines for physicians caring for
drug users that explicitly recommended that drug users be coun-
seled to "use a new, sterile syringe to prepare and inject
drugs."'" In light of the research evidence and these clinical
guidelines, we have previously argued that physicians treating
IDU patients should strongly consider protecting their patients
from blood-borne diseases by prescribing sterile injection
equipment when appropriate.1
2
In the past, physicians who wished to prescribe syringes
have been deterred by the widespread perception that it would
violate state and federal laws aimed at combating drug abuse. 13
Today, the medical evidence compels a reassessment of the le-
gality of providing injection equipment by prescription, because
many of the laws governing prescription and dispensing of in-
jection equipment employ, explicitly or implicitly, a standard of
medical necessity. Now that even previously hesitant federal
9 See David R. Holtgrave et a]., Cost and Cost-Effectiveness of Increasing
Access to Sterile Syringes and Needles as an HIV Prevention Intervention in the
United States, 18 J. ACQUIR. IMMUNE DEHc. SYNDR. & HUM. REROVIROLOGY S 133,
S136 (Supp. 11998).
10 See HELENE D. GAYLE ET AL, HIV PREVENTION BULLETIN: MEDICAL
ADVICE FOR PERSONS WHO INiECT ILLICIT DRUGS (U.S. Dep't of Health & Hum.
Serv., May 9, 1997); GUIDE TO CLINICAL PREVENTIVE SERVICES: REPORT OF THE U.S.
PREVENTIVE SERVICES TASK FORCE (Carolyn DiGuiseppi et al. eds., 2d ed. 1996); see
also San Francisco AIDS Found., Statements/Resolutions/Policies on Increased Ac-
cess to Clean Needles and Syringes (last modified Nov. 9, 1997)
<http://www.sfaf.org/prevention/needleexchange/statements.html> (collecting state-
ments from ten national organizations supporting the use of needle exchange pro-
grams and/or the use of sterile injection equipment).
1 GAYLEETAL., supra note 10, at4.
12 See Scott Burnis et al., Physician Prescribing of Sterile Injection Equipment
to Prevent HIV Infection: Time for Action, 139 ANNALS INTERNAL MED. 218 (2000).
13 See Lawrence 0. Gostin, The Legal Environment Impeding Access to Ster-
ile Syringes and Needles: The Conflict Between Law Enforcement and Public Health,
18 J. ACQUIR. IMMUNE DEPIC. SYNDR. & HUM. RETROVIROLOGY S60, S62-63 (Supp. I
1998); see also Alvin Novick, A Duty to Care: Sterile Injection Equipment and Il-
licit-Drug Use, I I AIDS & PUB. POL'Y J. 63, 65 (1996) (arguing that doctors should
realize that a patient's need for sterile injection equipment is a "legitimate medical
purpose"); Zita Lazzarini et al., In New York City, Syringe Laws and Regulations
Deter Physicians and Pharmacists from Prescribing and Selling Syringes to Persons
Who May Be Injection Drug Users, 18 1. ACQUIR. IMMUNE DEFIC. SYNDR. & HuM.
RETROVIROLOGY S 141, S142 (Supp. 11998).
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public health agencies are advising that access to sterile injec-
tion equipment is medically necessary to prevent serious dis-
ease,' 4 prescribing and dispensing such equipment in the course
of caring for IDU patients may reasonably be said to be legal in
many states and under federal law. Where legality is in doubt,
physicians and pharmacists have both the opportunity and a re-
sponsibility to their IDU patients to advocate for the elimination
of legal barriers to safe injection.
The public health problem of unsterile injection is not sim-
ply a matter of the ability to purchase a syringe. Law enforce-
ment practices that target individual drug users-relying both
on drug paraphernalia and drug possession laws-create an en-
vironment in which drug use is furtive and hidden.'5 People who
feel subject to search by the police are often reluctant to carry
syringes, even when they possess them, and so may not have a
clean syringe at the moment when drugs are available. The un-
derground quality of drug use leads some users to shooting gal-
leries or other concealed venues where clean water and other
hygienic amenities are lacking, which can contribute to the
transmission of infections. 16 The problem is probably worse for
people who are homeless, or lack a private, clean place for drug
use. 17 Urban black drug users, though a minority of drug users,
are most likely to be arrested, and so their willingness to carry
syringes may be disproportionately affected.' 8 Physicians and
pharmacists---indeed, all health care providers--can play an
important role in the ongoing reexamination of U.S. drug con-
trol policy, by advocating for drug users as people with medical
needs.
This article presents the results of a study of the laws gov-
erning physician prescription and pharmacy sale of syringes to
14 See infra notes 48-51 and accompanying text.
"" See Koester, supra note 6, at 290; Ricky N. Bluthenthal et al., Collateral
Damage in the War on Drugs: HIV Risk Behaviors Among Injection Drug Users, 10
INT'L J. o1 DRUG POL'Y 25 (1999) (indicating that the "war on drugs" has increased
needle sharing rather than decreasing it).
16 See Koester, supra note 6, at 292; see also Michael Marmor et al., Risk
Factors for Infection with Human immunodeficiency Virus Among Intravenous Drug
Abusers in New York Ci). 1 AIDS 39,43 (1987); Bourgois, supra note 6, at 2336.
17 See David D. Celentano et al., Risk Factors for Shooting Gallery Use and
Cessation Among Intravenous Drug Users, 81 AM. J. PuB. HEA 'H 1291 (1991).
18 See Ricky N. Bluthenthal et al., Drug Paraphernalia Laws and Injection-
Related Infectious Disease Risk Among Drug Injectors, 29 J. DR G ISSUES 1, 6, 9
(1999) (indicating that fear of arrest may increase needle sharing).
HEALTH MATRIX
injection drug users, covering all fifty states, Puerto Rico, and
the District of Columbia. It finds that, contrary to conventional
wisdom, the prescription of syringes to IDUs is clearly legal in
48 states and territories. It is clearly legal for pharmacists to fill
these prescriptions in 26 states and territories, and there is a rea-
sonable claim to legality in 22 more. We found only four juris-
dictions in which prescribing or dispensing were clearly illegal.
Part II of the article reviews the medical and public health
evidence on the value of syringe prescription and dispensing.
This section presents the epidemiologic and scientific evidence
linking unsafe injection practices to the transmission of highly
infectious blood-borne disease. Part II presents the results of
our legal analysis in summary form. In Part IV, we examine the
legality of prescribing a syringe under the laws of 52 states and
territories. Part V also investigates the regulatory scheme and
laws, this time with regard to dispensing injection equipment in
a pharmacy. Here, a careful examination of the legislative his-
tory of syringe regulation indicates that these regulatory provi-
sions were never intended to curtail legitimate medical care to
injection drug users. In a majority of states, the inapplicability
of paraphernalia laws to pharmacy sales of syringes by pre-
scription is so patent that we conclude that the practice is
clearly legal.
In Part VI, our analysis concludes with a discussion of how
laws might be changed or clarified to promote greater access to
injection equipment for IDUs through the health care system.
While physicians and pharmacists cannot stem the epidemic of
needle-borne infections on their own, prescription-based distri-
bution of injection equipment can contribute, not only to better
syringe access, but also to the public recognition of drug addic-
tion as a health problem that can be effectively addressed by the
health care system.
H. FURTIVE INJECTION, SYRINGE SCARCITY,
AND THE LAW: RESEARCH EVIDENCE
The immediate mechanism through which IDUs are in-
fected with HIV and hepatitis is not in dispute: blood containing
virus from an infected user in drug injection equipment is
transmitted to the next user of the equipment. This can happen
under several circumstances, including: (1) needle sharing, in
which a needle is used by two or more people serially; (2) re-
use, in which a previously used, unsterile needle is used later by
[Vol. 11:5
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another person, who may have found or purchased the needle
and may or may not believe that it was sterilized or even new;
and (3) unsterile drug preparation, which comprises behavior
including use of unsterile water, contact with another's blood,
and use of an unsterile needle to measure out shared drugs.19
The biological rationale for removing contaminated injection
equipment from circulation is supported by laboratory data that
indicate the durability of HIV in the syringe. Recent findings
show that the virus can survive in a syringe for periods in ex-
cess of four weeks. Individuals who reuse contaminated sy-
ringes are therefore susceptible to infection during this period.20
Indeed, use of an unsterile needle is well-documented as a
means of bacterial infection, whose unpleasant, sometimes fatal,
and often expensive consequences include abscesses, necrotiz-
ing faciaitis, and even damage to the heart. 2
1
A somewhat more disputed question, at least early in the
epidemic, was the reason for unsterile injection, particularly
needle sharing. Some early investigations attributed this largely
to social reasons, suggesting that needle sharing was a bonding
ritual. 22 Although it may often have social functions, more thor-
ough ethnographic and ecological studies have led to the con-
clusion that sharing is largely the result of the unavailability of
needles at the time of injection.23
Needles are very inexpensive, commonly costing between
ten cents and a quarter per needle, depending upon the quantity
purchased. They are manufactured each year in billions, and, in
the United States, move through an effective marketing and
distribution system. In the U.S., the main impediment to needle
access for drug users is law. As we discuss below, needles are
subject to considerable regulation as to their purchase; just as
important, under drug paraphernalia and needle prescription
laws, possession of a syringe can be the basis of arrest or at
19 See Koester, supra note 6, at 293; see also Bourgois, supra note 6.
2u See Nadia Abdala et al., Sunival of HIV-1 in Syringes, 20 L AcQUIR.
IMMUNE DEFIC. SYNDR. & Hum. RETROVIROLOGY 73,77 (1999).
21 See Charles E. Cherubin & Joseph D. Sapira, The Medical Complications of
Drug Addiction and the Medical Assessment of the Intravenous Drug User: 25 Years
Later, 119 ANNALs INTERNAL MED. 1017, 1018-19 (1993); see also Robyn R. M.
Gershon, Infection Control Basis for Recommending One-Time Use of Sterile Sy-
ringes and Aseptic Procedures for Injection Drug Users, 18 J. ACQUl,. IMMUNE
DEFIC. SYNDR. & HUM. REmROViROLOGY S20, S22 (Supp. 11998).
2- See Koester, supra note 6, at 287.
2' See id.
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least the pretext for a stop and frisk. Drug users report being
unwilling to carry needles for fear that it will mark them for
harassment or arrest.24 As a result, even people who possess
needles may not always carry them when purchasing drugs, and
may not have them on hand at the time of injection.w
The public health value of providing sterile injection
equipment is well-supported. Providing needles, through needle
exchanges and pharmacies, has been shown to be an effective
means of preventing blood-borne diseases. Since the mid-1980s,
IDUs have had ready legal access to clean needles in Australia
and much of Western Europe.2 6 Legal access to sterile injection
equipment, whether through over the counter sales, syringe ex-
change programs, or both, has become a standard public health
strategy for preventing further spread of HIV among IDUs in
nearly all other developed countries. 27 In the United States, sy-
ringe exchange programs (SEPs) have become especially com-
mon. These programs reduce the transmission of HIV and other
blood-borne infections associated with drug injection by pro-
viding sterile syringes and other "works," in exchange for used
and potentially contaminated needles. 28 In an official report to
Congress, Health and Human Services Secretary Donna Shalala
concluded that SEPs are "an effective component of a compre-
hensive strategy to prevent HIV and other blood borne infec-
24 See Bluthenthal et al., supra note 15, at 33.
25 For a review on how drug and needle access laws act as "structural factors"
that broadly influence IDU vulnerability to disease, see Don C. Des Jarlais, Struc-
tural Interventions to Reduce HIV Transmission Among Injecting Drug Users, 14
AIDS S41, S45-46 (Supp. 1 2000). See also Jennifer A. Taussig et al., Syringe Laws
and Pharmacy Regulations Are Structural Constraints on HIV Prevention in the US,
14 AIDS S47, S48 (Supp. I 2000) (arguing that criminalizing possession of drug
paraphernalia contributes to syringe sharing among IDUs who prefer not to carry
syringes for fear of arrest).26 See, e.g., Margaret MacDonald et al., HIV Prevalence and Risk Behaviour
in Needle Exchange Attenders: A National Study, 166 MED. J. Ausm. 237 (1997)
(studying the feasibility of using needle exchange programs as a means of measuring
HIV prevalence and related risk behaviors among injecting drug users). See generally
David L. Kirp & Ronald Bayer, The Politics, in DIMENSIONS OF HIV PREVENTION:
NEEDLE EXCHANGE 77 (Jeff Stryker & Mark D. Smith eds., 1993).
27 See Donald C. Des Jarlais & Samuel R. Friedman, Research, in Di-
MENSIONS OF HIV PREVENTION: NEEDLE EXCHANGE 63, 64 (Jeff Stryker & Mark
Smith eds., 1993). See generally Steffanie A. Strathdee et al., Can HIV Epidemics
Among Injection Drug Users Be Prevented?, 12 AIDS 12 S71 (Supp. A 1998).
2 See Centers for Disease Control & Prevention, Update: Syringe-Exchange
Programs - United States, 1996,46 MORBIDITY & MORTALITY WKLY. REP. 565. 565
(1997).
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tious diseases." 29 The National Institutes of Health convened a
panel of medical experts who agreed that, "[t]here is no longer
doubt that these programs work. 30 Most recently, the Surgeon
General reviewed the research data since 1998 and concluded
that "there is conclusive scientific evidence that syringe ex-
change programs, as part of a comprehensive HIV prevention
strategy, are an effective public health intervention that reduces
the transmission of HIV and does not encourage the use of ille-
gal drugs." 3' Numerous medical and scientific organizations
also validate the public health effects of syringe exchange. 32
Researchers studying SEPs have focused on reported
changes in behavior capable of transmitting HIV among SEP
clients. The epidemiologic data indicate that participants in
SEPs are less likely to share injection equipment and more
likely to use a new, sterile syringe for each injection as recom-
mended by public health officials. 33 Research findings also
29 Needle Exchange, Legalization, and the Failure of the Swiss Heroin Ex-
periments: Hearing Before the Subcomm. on Nat'l Sec., Int'l Affairs and Criminal
Justice of the Comm. on Gov't Reform and Oversight, House of Representatives,
105th Cong. 118, 129 (1997) (report of Donna E. Shalala, Secretary of Health &
Human Services).
30 National Inst. of Health, Consensus Statement: Interventions to Prevent
HIV Risk Behaviors (Feb. 11-13, 1997)
< http:llodp.od.nih.govlconsensuslconsllO410L4_statement.htm> (visited Sept. 26,2000). 2 1 Evidence-Based Findings on the Efficacy of Syringe Exchange Programs,
supra note 2.
312 Organizations supporting access to sterile syringes include the: American
Bar Association, American Medical Association, American Public Health Associa-
tion, Association of State and Territorial Health Officers, Centers for Disease Control
and Prevention, National Academy of Sciences, National Association of State AIDS
Directors, National Institutes of Health Consensus Panel, Office of Technology As-
sessment of the U.S. Congress, President Bush's and President Clinton's AIDS Advi-
sory Commissions.
"-1 See HUMAN RESOURCES Div., U.S. GEN. ACCOUNTING OFFICE, AIDS AND
NEEDLE EXCHANGE PROGRAMS 1, 7-8 (Mar. 23, 1993) (reporting to the Select Com-
mittee on Narcotics Abuse & Control that evidence suggests needle exchange pro-
grams have potential as an HIV/AIDS prevention strategy); Holly Hagan et al., An
Interview Study of Participants in the Tacoma, Washington, Syringe Exchange, 88
ADDICTION 1691, 1694 (1993); Denise Paone et al., New York City Syringe Ex-
change: An Overview, 1994 NAT'L RESEARCH COUNCIL & INST. OF MED., PROC.
WORKSHOP ON NEEDLE EXCHANGE & BLEACH DISTRIBUTION PROGRAMS 47, 55;
Kathy Oliver et al., Behavioral and Community Impact of the Portland Syringe Ex-
change Program,1994 NAT'L RESEARCH COUNCIL & INST. OF MED., PROC.
WORKSHOP ON NEEDLE EXCHANGE & BLEACH DISTRIBUTION PROGRAMS 35, 37; John
K. Watters et al., Syringe and Needle Exchange as HIV/AIDS Prevention for Injec-
tion Drug Users, 271 JAMA 115, 118 (1994); Don C. Des Jarlais & Samuel R.
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show a reduced risk of HIV infection among SEP participants.34
In one such study, IDU HIV rates were compared for cities with
and without SEPs. On average, seroprevalence increased by
5.9% per year in the 52 cities without SEPs, and decreased by
5.8% per year in the 29 cities with SEPs. The average annual
change in seroprevalence was 11% lower in cities with SEPs.35
A second study estimated that between 4,394 and 9,666 new
cases of HIV could have been prevented between 1987 and
1995 had syringe exchange programs been implemented in the
United States during the early stages of the AIDS epidemic.
36
Currently, 31 states and territories have SEPs in operation,
including 10 with statutes explicitly authorizing such programs.
These programs typically offer an array of services for IDUs. Of
87 programs surveyed in 1996, 97% provided referral to sub-
stance abuse treatment, 80% provided education to reduce the
risk of STDs, while many others provided primary health care,
Friedman, AIDS and the Use of Injected Drugs, Sc. AM., Feb. 1994, at 82, 85-87;
Merrill Singer et al., Sale and Exchange of Syringes, 10 . ACQUIR. IMMUNE DEFIc.
SYNDR. & HUM. RmROVROLOGY 104 (1995); David Vlahov et al., Reductions in
High-Risk Drug Use Behaviors Among Participants in the Baltimore Needle Ex-
change Program, 16 J. ACQUR. IMMUNE DEFic. SYNDR. & HUM. RETROVfROLOGY
400, 403 (1997); see also Robert Heimer et al., Syringe Use and Reuse: Effects of
Syringe Exchange Programs in Four Cities, 18 J. ACQUIR. IMMUNE DEFic. SYNDR. &
HUM. RETROVIROLOGY S37 (Supp. I 1998); Ricky N. Bluthenthal et al., Use of an
Illegal Syringe Exchange and Injection-Related Risk Behaviors Among Street-
Recruited Injection Drug Users in Oakland, California, 1992-1995, 18 J. AcQuiR.
IMMUNE DEFIC. SYNDR. & HUM. RmuROvIRoLOGY 505 (1998); Holly Hagan et al.,
Reduced Injection Frequency and Increased Entry and Retention in Drug Treatment
Associated with Needle-Exchange Participation in Seattle Drug Injectors, 19 J.
SUBSTANCE ABUSE TREATMENT 247, 251 (2000). See generally Ernest Drucker et al.,
Measuring Harm Reduction: The Effects of Needle and Syringe Exchange Programs
and Methadone Maintenance on the Ecology of HIV, 12 AIDS S217 (Supp. A 1998)
(reviewing research studies).
34 See Edward H. Kaplan & Robert Heimer, HJV Incidence Among New Ha-
ven Needle Exchange Participants: Updated Estimates from Syringe Tracking and
Testing Data, 10 . ACQUIR. IMMUNE DEFYc. SYNDR. & HUM. RETROVIROLOGY 175,
176 (1995); Don C. Des Jarlais et al., HIV Incidence Among Injecting Drug Users in
New York City Syringe-Erchange Programmes, 348 LANCET 987, 990 (1996); Susan
F. Hurley et al., Effectiveness of Needle-Exchange Programmes for Prevention of
HIV Infection, 349 LANCET 1797 (1997); see also Rafaela R. Robles et al., Syringe
and Needle Exchange as HIV/AIDS Prevention for Injection Drug Users in Puerto
Rico, 45 HEALTH POL'Y 209, 209 (1998).
35 See Hurley et al., supra note 34, at 1799.
36 See Peter Lurie & Ernest Drucker, An Opportunity Lost: HIV Infections
Associated with Lack of a National Needle-Exchange Programme in the USA, 349
LANCET 604, 606 (1997).
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tuberculosis screening, and HIV counseling and testing.37 Al-
though lowering HIV rates is the primary goal of needle ex-
change, other outcomes have been found. These include reduced
drug use, lower rates of criminal activity for profit, and greater
entry and retention in drug treatment programs.38
Syringe exchange programs are not a panacea for the AIDS
epidemic." If the availability of clean syringes fails to meet the
needs of the IDU population in a given community, redistribu-
tion of used equipment can occur and subsequently affect HIV
incidence. Unfortunately, the existing network of some 134
SEPs cannot on its own satisfy the needs of IDUs in the U.S.
Estimates of the annual number of syringes required to meet the
Health and Human Service's single-use recommendation run in
the range of one billion.40 The most recent estimate of the num-
.17 See Denise Paone et al., Syringe Exchange in the United States, 1996: A
National Profile, 89 AM. J. PuB. HEALTH 43, 44-45 (1999) (discussing and compar-
ing survey results regarding U.S. syringe exchange activities).
3 See Robert Brooner et al., Drug Abuse Treatment Success Among Needle
Exchange Participants, 113 PUB. HEALTH REP. 129, 138 (Supp. I 1998); see also
Hagan et al., Reduced Injection Frequency and Increased Entry and Retention in
Drug Treatment Associated with Needle-Exchange Participation in Seattle Drug
Injectors, supra note 32, at 248-50 (finding that one-third of IDUs reported substan-
tially fewer injections after the needle-exchange program ended); Hagan et al., An
Inteniew Study of Participants in the Tacoma, Washington, Syringe Exchange, supra
note 32, at 1694-95 (concluding that participation in syringe exchange program was
associated with significant decline in high-risk injection practices).
" See Julie Bruneau et al., High Rates of HIV Infection Among Injection Drug
Users Participating in Needle Exchange Programs in Montreal: Results of a Cohort
Study, 146 AM. J. EPIDEMIOLOGY 994, 1001 (1997) (suggesting that NEPs are only
successful in reducing the spread of IHV if distribution meets the needs of the drug
population); Julie Bruneau et al., Assessing Harm Reduction Strategies: The Dilemma
of Observational Studies, 146 AM. J. EPmEMIOLOGY 1007, 1010 (1997). Although the
Montreal study is sometime cited as evidence that SEP does not work, the authors of
the study themselves took the unusual step of disclaiming that interpretation of their
data. See Julie Bruneau & Martin T. Schechter, The Politics of Needles and AIDS,
N.Y. TIMS, Apr. 9, 1998, at A27 (arguing insufficient Canadian syringe volume
explains author's study reporting the inability of needle exchange programs to reduce
the spread of blood-borne disease). Subsequent data from the Montreal cohort indi-
cate that there was no correlation between HIV seroconversion and NEP use. See J.
Bruneau et al., Changes in HIV Seroconversion Rates of IDUs Attending Needle Ex-
change Programs (NEP) in Montreal: The Saint-Luc Cohort, 10 CAN. J. INFEC'IOuS
DISEASE 45B (Supp. B 1999).
40 See Peter Lurie et al., A Sterile Syringe For Every Drug User Injection:
How Many Injections Take Place Annually, and How Might Pharmacists Contribute
to Syringe Distribution?, 18 J. AcQuIR. IMUNE DEFIC. SYNDR. & HUM. RIRmO-
VIROLOGY S45, S46-47 (Supp. 11998).
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ber of syringes distributed by SEPs in the United States, how-
ever, was only 17.5 million in 1997. 4'
Many policies, including those governing access to drug
treatment, the sale of needles by pharmacies, and the arrest of
IDUs for possessing needles, influence the spread of HIV.42
There is no doubt, however, that physician prescription of ster-
ile needles and syringes is an important and effective tool in
harm reduction to minimize HIV transmission among IDUs,
their partners, and their children. While pharmacy provision of
sterile syringes has increasingly been advocated as a method to
supply sterile syringes, many pharmacists do not sell syringes to
suspected IDUs,43 and may demand a prescription even in states
without prescription laws.44 Furthermore, there is evidence that
some pharmacists are less willing to sell syringes to African-
American prospective buyers.45 A prescription, even if not re-
quired, could persuade a pharmacist to exercise his or her dis-
cretion to sell syringes in a particular case. The preferences of
JDUs themselves are also an important factor. Some may prefer
the ready access to ancillary services offered at a SEP, others
the anonymity of a pharmacy, and still others the access to
medical care offered by a physician prescribing syringes. All
these preferences may vary as times and needs change for the
individual, and so the goal of sterile injection is served by pro-
viding a variety of access options.
41 See Centers for Disease Control & Prevention, Update: Syringe-Exchange
Programs - United States, 1997,47 MoRBiDnrY & MoRTALinY WKLY. REP. 652, 653
(1998).
42 See Robert Heimer et al., Structural Impediments to Operational Syringe-
Exchange Programs, 11 AIDS & PuB. PoL'Y J. 169 (1996).
43 See Patricia Case et al., Access to Sterile Syringes in Maine: Pharmacy
Practice After the 1993 Repeal of the Syringe Prescription Law, 18 J. AcQUIR.
IMMUNE DEFic. SYNDR. & HUM. Rm'RoVIROLOGY S94 (Supp. 1 1998) (finding that
even when the sale of syringes without a prescription is legal, many pharmacists still
choose not to sell syringes to suspected drug users).
4See Wilson M. Compton III et al., Legal Needle Buying in St. Louis, 82 AM.
J. PUB. HEALTH 595, 596 (1992); Taussig et al., supra note 25, at S50 (explaining that
in Maine, pharmacists were still hesitant about selling syringes to suspected IDUs
despite that legislature removing the prescription requirement for syringes sales);
Alice A. Gleghorn et al., Pharmacists' Attitudes About Pharmacy Sale of Nee-
dles/Syringes and Needle Exchange Programs in a City Without Needle/Syringe Pre-
scription Laws,18 J. ACQUIR. IMMUNE DEFIC. SYNDR. & HUM. RETROVIROLOGY S89,
S92 (Supp. 1 1998); F. Stephen Bridges et al., Sale of Nonprescription Syringes to
Men and Women - Florida, 1994-1995, 10 FLA. . PuB. IIALT 12, 15 (1998).45See Compton et al., supra note 44, at 596 (stating that African-Americans
were denied syringes possibly due to racial bias).
(Vol. 11:5
2001] HARM REDUCTION IN THE HEALTH CARE SYSTEM 17
Approximately two-thirds of individuals with addiction will
see a primary care or urgent care physician every six months,
and many, others are regularly examined by other medical spe-
cialists .4° This means that physicians can play an important role
in addressing substance abuse and its devastating health conse-
quences.4 7 Physician prescription of injection equipment has the
potential to make a difference in a number of ways:
(1) It affords access to needles and ensures that they can
be legally carried.
(2) It entails access to a health care provider who may
be able to help the patient enter and complete drug
treatment.
(3) It provides an incentive for injection drug users to
seek medical treatment.
(4) It creates an opportunity for other harm reduction
measures (e.g., counseling on drug overdose and pre-
scription of naloxone).
A recent HIV/AIDS Prevention Bulletin from the U.S. De-
partment of Health and Human Services essentially establishes a
standard of care for IDU patients (See Table 1).41 In the docu-
ment, the federal agencies responsible for drug-related public
health issues--the Centers for Disease Control and Prevention
(CDC), the National Institute on Drug Abuse, the Health Re-
sources and Services Administration, and the Substance Abuse
and Mental Health Services Administration--suggest that health
care workers counsel IDUs who continue to inject to "use a new
sterile syringe to prepare and inject drugs." This approach has
also been endorsed by medical and public health organizations
including the U.S. Preventive Services Task Force,49 the Ameri-
46 See Alan I. Leshner, Science-Based Views of Drug Addiction and Its
Treatment, 282 JAMA 1314, 1314 (1999).47 Drug users are a medically underserved population. Economic and cultural
barriers combine to reduce their willingness to access care and their satisfaction with
the care they do receive. Physicians have increasingly recognized a need to find new
ways to reach IDUs in medical need. See Nathaniel Gunn et al., Primary Care as
Harm Reduction for Injection Drug Users, 280 JAMA 1191 (1998).
48 GAYLE ET AL., supra note 10, at 4.49 See GUIDE TO CLINICAL PREVENTIVESERVICES, supra note 10.
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can Medical Association, and the Association of State and Ter-
ritorial Health Officials.50 In June 2000, the American Medical
Association approved a resolution asking that "our [AMA]
strongly support the ability of physicians to prescribe syringes
and needles to patients with injection drug addiction in con-
junction with addiction counseling in order to help prevent the
transmission of contagious diseases." 51
Table I. U.S. Department of Health and Human Services
Provisional Recommendations to Drug Users Who
Continue to Inject
Stop using and injecting drugs
Enter and complete substance abuse treatment, including relapse prevention
Take the following steps to reduce personal and public health risks, if
injection drug use persists:
Never reuse or "share" syringes, water, or drug preparation equipment
Use only syringes obtained from a reliable source (e.g., pharmacy)
Use a new, sterile syringe to prepare and inject drugs
If possible, use sterile water to prepare drugs; otherwise, use clean
water from a reliable source (such as fresh tap water)
Use a new or disinfected contained ("cooker") and a new filter
("cotton") to prepare drugs
Clean the injection site before injection with a new alcohol swab
Safely dispose of syringes after one use
Physician prescription and pharmacy sales of sterile injec-
tion equipment to IDUs makes sense from both a public health
and clinical health care standpoint. Yet because it involves drug
use and injection equipment that are subject to at least some
regulation in most states, the practice's legality must be consid-
ered along with its possible benefits. This article reports the re-
sults of detailed legal research on the question, and provides an
overview of the legal issues presented.
50See San Francisco AIDS Found., supra note 10.
51 American Med. Ass'n, Infectious Disease Issues Acted on by the AMA
House of Delegates (last modified June 22, 2000) <http://www.ama-
assn.orglama/pub/article/1818-2698.html> (reporting Resolution 416-Physician Pre-
scription of Needles to Addicted Patients).
[Vol. 11:5
2001] HARM REDUCTION IN THE HEALTH CARE SYSTEM 19
I. RESULTS IN SUMMARY: THE LEGALITY OF
PHYSICIAN PRESCRIPTION AND
PHARMACY SALES
To determine the legality of prescribing and dispensing sy-
ringes to known IDU patients, we collected statutes, regulations
and case law governing medical and pharmacy practice, and sy-
ringe access, for all fifty states, Puerto Rico, and the District of
Columbia. A separate analytic memorandum was prepared for
each state and territory.52
Table II. The Legality of Prescribing and Dispensing Sterile
Injection Equipment to IDUs to Prevent Disease Transmission 3
State Pres. Para. Comments Prescribing Dispensing
law? law? legal? legal?
Y ? N Y ? N
AL X X X
AK Local drug para- X x
phernalia ordinances
in several cities
AR X X X
AZ X X X
2 The memoranda are available on the Internet. See Temple University of the
Commonwealth System of Higher Education, Beasley School of Law, Project on
Harm Reduction in the Health Care System (Nov. 10, 1999)
<http:llwww.temple.edu/lawschoollaidspolicyldefault.htm> [hereinafter Project on
Harm Reduction].
3 A web of state syringe prescription, drug paraphernalia, and pharmacy
practice rules restrict the sale and possession of syringes and needles:
Syringe prescription laws (denoted Pres. law in table) require a prescription
for the sale or possession of injection equipment. These laws were enacted to remedy
the abuse of prescribing opiates like morphine during the late nineteenth and early
twentieth centuries. Physician prescription practices, however, no longer contribute to
illicit drug use since the medical profession is now subject to strict regulation.
Paraphernalia laws (denoted Para. law in table) were primarily enacted in the
1960s and 1970s to regulate the growth of the drug paraphernalia industry. These
laws restricted the manufacture, sale, distribution, and possession of items like rolling
papers, bongs, pipes, freebasing kits, and in some states, needles. In 1979, the Justice
Department's Drug Enforcement Administration (DEA) promulgated the Model Drug
Paraphernalia Act (see U.S. DRUG ENFORCEMENT ADMIN., U.S. DEP'T OF JUSTICE,
DRUG ENFORCEMENT 29 (Mar. 1980).
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State Pres. Para. Comments Prescribing Dispensing
law? law? legal? legal?
Y ? N Y ? N
CA X X X X
CO X Paraphernalia law X X
does not mention
syringes; pharmacy
law provides immu-
nity to pharmacists
filling valid pre-
scriptions.
CT X X Paraphernalia law X X
excludes < 31 sy-
ringes; prescription
law excludes < 11
DE X X Prescription law X x
limits syringe pos-
session to those for
whom it is "neces-
sary for the treat-
ment of an injury,
deformity or disease
then suffered."
DC X If authorized by X X
comnmissioner of
health under needle
exchange law.
FL X X Prescription re- X X
quired for sale to
minors.
GA X Syringe sales re- X X
quire legitimate
medical purpose but
prescription not
required.
HI X X X
ID X X X
IL X X X X
IN X Paraphernalia law X X
exempts sellers of
items "historically
and customarily
used in connection
with the ... injecting
... of ... lawful sub-
stancefs]."
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State Pres. Para. Comments Prescribing Dispensing
law? law? legal? legal?
Y ? N Y ? N
IA X Paraphernalia law X X
excludes syringes
distributed for a
"lawful purpose."
KS X Case law narrowly X X
interprets "legiti-
mate medical pur-
pose."
KY X Syringe sale law X X
places detailed re-
strictions on sales.
LA X Paraphernalia law X X
explicitly excludes
items distributed for
medical use.
ME X X Sale of< I Isy- X X
ringes unrestricted
MD X Board of Pharmacy X X
has implied pharma-
cist discretion, ex-
tends to dispensing
syringes to prevent
disease.
MA X X X X
MI X Dispensing legal if X X
authorized for dis-
ease prevention
purposes by any
state or local
agency.
MN X Prescription or sale X X
of < 11 syringes
only
MS X X X
MO X X X
MT X Paraphernalia law X X
exempts physicians
and pharmacists.
NE X X X
NV X X Prescription re- X X
quired except for
insulin, asthma, and
other specified uses.
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State Pres. Para. Comments Prescribing Dispensing
law? law? legal? legal?
Y ? N Y ? N
NH X X Effective 1/1/2001, X X
prescription law
excludes < I I sy-
ringes for adults and
paraphernalia law
no longer applies to
injection equipment.
NJ X X X X
NM X Department of X X
Health could ap-
prove prescrip-
tion/pharmacy based
harm reduction pro-
gram.
NY X X Prescription law X X
excludes < 11 sy-
ringes and para-
phernalia law ex-
empts syringes sold
pursuant to the pre-
scription law (as of
11/2001). Com-
missioner of Health
also has authority to
authorize dispensing
by prescription or
otherwise.
NC X X X
ND X X X
OH X Specific syringe X X
possession and dis-
tribution statute
controls; physicians
and pharmacists
exempt from para-
phernalia law.
OK X X X
OR X Paraphernalia law X X
excludes syringes.
PA X X Prescription re- X X
quired for sale by
pharmacy regula-
tion.
PR X X
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State Pres. Para. Comments Prescribing Dispensing
law? law? legal? legal?
Y ? N Y ? N
RI X Director of Health, X X
and medical and
pharmacy boards
have approved a
program of physi-
cian prescription
and pharmacy sales.
As of 911/2000,
prescription law will
be repealed and
paraphernalia law
will exclude injec-
tion equipment.
SC X Syringes separately X X
regulated; parapher-
nalia law does not
include "injection"
or syringes, and
does not apply to
heroin use.
SD X X X
TN X Paraphernalia law X X
exempts physicians
and pharmacists;
buyer must show
I "medical need."
TX X X X
UT X X X
VT X If authorized by X X
commissioner of
health under needle
exchange law.
VA X X Syringe law governs X X
medical distribution
and requires pre-
scription for chil-
dren under 16.
WA X Pharmacy regulation X X
to clarify legality of
unrestricted sales
pending.
WV X Paraphernalia law X X
allows sale by licen-
sees such as phar-
macists.
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State Pres. Para. Comments Prescribing Dispensing
law? law? legal? legal?
Y ? N Y ? N
WI X Paraphernalia law X X
1 excludes syringes.
WY X _X X
Total 13 _I 48 2 2 26 22 14
The question of the legality of prescribing and dispensing
syringes brings the analyst into territory that is at once highly
developed and quite obscure. The legality of needle exchange
has been the subject of legal analysis5 and litigation.55 Yet even
the issue of needle exchange program legality continues to in-
volve dispute. Providing syringes by physician prescription and
pharmacy sales requires a quite different analysis than needle
provision by unlicensed lay people. Unlike the lay exchanger,
the physician has considerable authority to prescribe drugs and
devices, and pharmacists are usually required to fill valid pre-
scriptions. In the following sections, we explain the reasoning
we used to reach the conclusions summarized in Table II.
For each state and territory assessed, we asked three specific
questions:
5 See Lawrence 0. Gostin & Zita Lazzarini, Prevention of HIVIAIDS Among
I4ection Drug Users: The Theory and Science of Public Health and Criminal Justice
Approaches to Disease Prevention, 46 EMoRY L.J. 590 (1997) (reviewing the legality
of syringe exchange programs); Scott Burris et a]., The Legal Strategies Used in Op-
erating Syringe Exchange Programs in the United States, 86 AM. J. PUB. HEALTH
1161 (1996) (exploring State responses to needle exchange programs); Laura
Ferguson et al., Syringe Exchange in Pennsylvania: A Legal Analysis, 8 TEMP. POL.
& Civ. RTS. L. REV. 41 (1998).
55 See Commonwealth v. Leno, 616 N.E.2d 453 (Mass. 1993) (holding that
defendants were not entitled to necessity defense after violating statutes restricting
possession and distribution of syringes during operation of needle-exchange pro-
gram); State v. McCague, 714 A.2d 937 (N.J. Super. CL App. Div. 1998) (rejecting
the defenses of medical necessity and "de minimus infractions" in upholding convic-
tions for furnishing or giving hypodermic needles as part of an exchange program);
People v. Bordowitz, 588 N.Y.S.2d 507 (N.Y. Crim. Ct. 1991) (upholding necessity
defense in charge under the state hypodermic needle possession statute where defen-
dants were distributing clean needles in an exchange program); Spokane County
Health Dist. v. Brockett, 839 P.2d 324 (Wash. 1992) (holding needle exchange pro-
gram legal based on the broad powers of local health boards to institute efforts to
prevent the spread of HIV).
[Vol. 11:5
2001] HARM REDUCTION IN THE HEALTH CARE SYSTEM 25
1) May a physician legally prescribe sterile injection
equipment to an IDU patient?
2) May a pharmacist legally fill such a prescription?
3) How might state law be changed or clarified to pro-
mote access to sterile injection equipment for IDUs
through the health care system?
IV. MAY A PHYSICIAN LEGALLY PRESCRIBE
STERILE INJECTION EQUIPMENT TO
AN IDU PATIENT?
Answering this question required a two-step analysis. We
determined first whether prescription of sterile injection equip-
ment was consistent with the general law governing medical
practice in each state. If so, we then asked whether any other
law, such as a drug paraphernalia provision, prohibited pre-
scription of syringes to an IDU patient. We begin with an over-
view of the regulatory environment.
A. The Regulatory Scheme
1. Medical Licensure Law
All states regulate the practice of medicine.56 The common
regulatory structure includes a statute setting out basic require-
ments for licensure and standards of professional practice.57
These statutes are administered by medical boards, which nor-
mally have the authority to issue further regulations and the re-
sponsibility to enforce practice rules through disciplinary ac-
6 See, e.g., ALA. CODE §§ 34-24-50-34-24-508 (1997 & Supp. 1999); CAL.
Bus. & PROF. CODE § § 2000-2027 (West 1990 & Supp. 2000); D.C. CODE ANN. §§
2-3301.IB2-3312.1 (1994 & Supp. 2000); MASs. GEN. LAws ANN. ch. 112, §§ 2-9B
(West 1996 & Supp. 2000); N.J. STAT. ANN. §§ 45:9-1-45:27.9 (West 1991 & Supp.
2000); N.Y. EDUC. LAw §§ 6520-29 (McKinney 1985 & Supp. 2000); PA. STAT.
ANN. tit. 63, §§ 422.1-.45 (West 1996 & Supp. 2000); TEx. Occ. CODE ANN. §§
151.001-164.204 (West 2000).
. See, e.g., ALASKA STAT. § 08.64.100 (Michie 1998); COLO. Rv. STAT. §
12-36-104(1)(a) (1999); DEL. CODE ANN. tit. 24, §§ 1720-39 (1997); FLA. STAT.
ANN. § 458.309 (West 2000); KAN. ADMiN. REGS. 100-6-1-100-16-4.
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tion.58 In a few states, professional discipline is under the juris-
diction of a separate board or agency with responsibility for
multiple regulated professions. 59 Physicians who fail to main-
tain the required standards are subject to discipline up to and
including revocation of their license.
60
Medical licensure law almost never explicitly addresses the
physician's general authority to write prescriptions for or dis-
pense drugs and devices.61 It appears that the physician's
authority to prescribe medically necessary drugs and devices in
the course of providing care is so inherent and accepted a part
of medical practice that no explicit authorization is required.
Leaving aside any limitations imposed by other laws, a physi-
cian is free to prescribe any drug or device she believes will
benefit the patient and the prescription of which is consistent
with the accepted standard of care.
Medical practice laws set out basic standards of profes-
sional practice, usually in the form of a list of acts that consti-
tute "unprofessional conduct." These lists identify specific ille-
gal practices. Oklahoma's list is illustrative:
58 See, e.g., CAL. Bus. & PROF. CODE § 2234 (West Supp. 2000); FLA. STAT.
ANN. § 458.331 (West Supp. 2000); IOWA CODE ANN. §§ 135.31, 272C.3-272C.4
(West 1997 & Supp. 2000); N.H. REV. STAT. ANN. § 329:2 (1995 & Supp. 1999); PA.
STAT. ANN. tit. 63, § 422.41(8)(ii) (West 1996).
59 See, e.g., D.C. CODE ANN. § 2-3303.1 (1994); N.Y. EDuC. LAW § 6506
(McKinney 1985 & Stpp. 2000); OR. REv. STAT. § 677.265 (1999); WASH. REV.
CODEANN. § 18.71.002 (West 1999).
60 See, e.g., Evers v. Board of Med. Exam'rs, 516 So.2d 650 (Ala. Civ. App.
1987) (refusing to issue an injunction restricting Alabama's State Medical Licensure
Commission from investigating physician's "herbal tumor removal" system); Storrs
v. State Med. Bd., 664 P.2d 547 (Alaska 1983) (affirming medical board's decision to
revoke physician's license on grounds of professional incompetency); Ghani v. De-
partment of Health, 714 So.2d 1113 (Fla. Dist. Ct. App. 1998) (holding on appeal that
physician's conduct did not fall below the standard of care and, therefore, the disci-
plinary actions of the Board of Medicine were not warranted); Hasbun v. Department
of Health, 701 So.2d 1235 (Fla. Dist. Ct. App. 1997) (holding that while testimony
failed to support the imposition of disciplinary measures for violating the standard of
care, a physician may nevertheless be subject to discipline for exploiting his or her
patient for personal financial gain); Pennsylvania Med. Soc'y v. State Bd. of Med.,
546 A.2d 720 (Pa. Commw. Ct. 1988) (addressing provisions regarding the regula-
tory authority of the State Board of Osteopathic Medicine),
61 For an exception, see KAN. STAT. ANN. § 65-2837b (Supp. 1999) (limiting
the physician's general authority to write prescriptions for or dispense drugs within
its designation of "unprofessional conduct"). See also 35 PA. CONS. STAT. ANN. §
780-11 l(d) (West Supp. 2000) (authorizing prescription of drugs and devices).
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(1) Indiscriminate or excessive prescribing, dispensing
or administering of Controlled or Narcotic drugs....
(6) Dispensing, prescribing or administering a Con-
trolled substance or Narcotic drug without medical
need....
(10) [C]onviction of a felony or any offense involving
moral turpitude whether or not related to the practice of
medicine and surgery.
(11) Conduct likely to deceive, defraud, or harm the
public....
(15) Gross or repeated negligence in the practice of
medicine and surgery....
(25) Except as otherwise permitted by law, prescribing,
selling, administering, distributing, ordering, or giving
to a habitue or addict or any person previously drug de-
pendent, any drug legally classified as a controlled sub-
stance or recognized as an addictive or dangerous
drug.
62
These standards tend to explicitly turn on the medical justi-
fication for the care provided, and so whether a practitioner has
violated these standards requires reference to general profes-
sional standards. Often, compliance with general medical stan-
dards is itself an explicit requirement for practice. Pennsylva-
nia's Medical Practice Act, for example, states:
A practitioner departs from, or fails to conform to, a
quality standard of the profession when the practitioner
provides a medical service at a level beneath the ac-
cepted standard of care. The board may promulgate
regulations which dtefine the accepted standard of care.
In the event the board has not promulgated an applicable
regulation, the accepted standard of care for a practitio-
ner is that which would be normally exercised by the
average professional of the same kind in this Common-
"2 OKLA. ADMIN. CODE § 435:10-74 (2000).
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wealth under the circumstances, including locality and
whether the practitioner is or purports to be a specialist
in the area.
63
A court will assess a practice alleged to be unprofessional
and beneath the standard of acceptable care "[b]y considering
what the practitioner has done in the particular circumstances,
and by comparing his conduct with what a 'responsible segment
of the medical profession' would say should have been done."
64
Conviction of a felony violation under state or federal con-
trolled substances laws is a separate ground for discipline in
virtually every state,65 and often stands as the basis for auto-
matic suspension of a practitioner's medical license.
66
2. Controlled Substances Law Generally
All states have in place detailed regulations governing
drugs that are regarded as always or potentially subject to
abuse.67 These generally follow the format of the Federal Con-
63 63 PA. CONS. STAT. ANN. § 422.41(8)(ii) (West 1996); accord IND. ADMIN.
CODE tit. 844, r. 5-1-1 (1996); Na. REv. STAT. § 71-148 (1996); OR. Ray. STAT. §
677.265 (1)(c) (1999); VA. CODEANN. § 54.1-2914 (Michie 1998).
64 Commonwealth v. Stoffan, 323 A.2d 318, 328 (Pa. Super. Ct. 1974) (refer-
ring to a practitioner's choice of either physically/visually examining a person or
foregoing such an exam if he is convinced by evidence that the person is not drug-
dependent when making a decision to prescribe a controlled substance); accord State
Bd. of Med. Educ. & Licensure v. Ferry, 94 A.2d 121, 123 (Pa. Super. Ct. 1953).
"Generally speaking, apart from, or in the absence of, statutory definitions, what
constitutes unprofessional conduct.., must be determined by those standards which
are commonly accepted by those practicing the same profession in the same territory.
In determining what constitutes dishonorable conduct every case must be determined
on its own particular facts." Id.
65 See, e.g., CONN. GEN. STAT. ANN. § 20-13c(5) (West 1999); DEL CODE
ANN. tit. 24, § 1731 (1997); NEv. RPv. STAT. ANN. § 630.306(3) (Michie 2000);
OKLA. ADMIN. CODE § 435:10-7-4(27) (2000); TEx. OCC. CODE ANN. §§ 164.051 &
164.057 (West 2000).
6 See, e.g., ALA. CODE § 34-24-360(6) (1997 & Supp. 1999) (authorizing
Medical Licensure Commission to suspend any license to practice medicine when-
ever the licensee is found guilty of violating state or federal laws pertaining to con-
trolled substances); ARiz. REv. STAT. ANN. § 13-3414 (West 1989) (stating that if a
person is convicted of a drug offense, the court has the discretion to suspend or re-
voke licensure or registration); FLA. STAT. ANN. § 893.11 (West 2000); PA. STAT.
ANN. tit. 63, § 422.40(b) (West 1996).
67 See, e.g., ALASKA STAT. § 17.30.080(a) (Michie 1998); CAL. HEALTH &
SAFETY CODE § 11153(a) (West Supp. 2000); GA. CODE ANN. § 16-13-41 (1996);
720 ILL. COMP. STAT. ANN. 570/100 (West Supp. 2000); MONT. CODE ANN. § 50-32-
208 (1999); S.C. CODE ANN. § 44-53-360(h) (Law. Co-op. 1985); TENN. CODE ANN,
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trolled Substances Act.68 Drugs deemed to have the potential for
abuse are placed by statute or regulation on one of five sched-
ules. All scheduled drugs are subject to more or less strict limi-
tations on prescription, dispensing, and use. As we will discuss
further below, either by statute or by case law or both, con-
trolled substances in nearly every state can only be prescribed
for a legitimate medical purpose by a physician acting in good
faith in the normal course of professional practice. Although the
term "controlled substance" is never defined to include syringes
or other medical devices, 69 these statutes are highly relevant to
our analysis because they, and the case law under them, provide
the only explicit legal standard under state law for assessing the
validity of a prescription. 7 °
A minority of states' controlled substances laws include an
explicit prohibition of physicians prescribing controlled sub-
stances to drug dependent persons, unless the physician is le-
gally authorized to provide drug treatment services (in the case,
for example, of methadone) or the drug is prescribed for some
§§ 39-17-401--433 (1997 & Supp. 1999); Wyo. STAT. ANN. § 35-7-1030(d) (Michie
1999).
" 21 U.S.C.S. § 841 (Law. Co-op. 1997 & Supp. 2000).
69 See, e.g., ALASKA STAT. § 11.71.900(4) (Michie 1998) (defining "con-
trolled substance" as "a drug, substance, or immediate precursor"); COLO. REv. STAT.
§ 18-18-102(5) (1999); FLA. STAT. ANN. § 893.02(4) (West 2000); see also FLA.
STAT. ANN. § 499.003(10) (West Supp. 2000) (defining "device"); HAw. REv. STAT.
§ 329-1 (1993); KAN. STAT. ANN. § 65-4101(e) (Supp. 1999).
70 Many states place their drug paraphernalia or syringe laws within the tite
of their statutes covering controlled substances. We found only one state, however,
whose rules on prescribing controlled substances included explicit coverage of de-
vices. Pennsylvania's Controlled Substance, Drug, Device and Cosmetic Act includes
the following unique provision:
A practitioner may prescribe, administer, or dispense a controlled sub-
stance or other drug or device only (i) in good faith in the course of his
professional practice, (ii) within the scope of the patient relationship, and
(iii) in accordance with treatment principles accepted by a responsible
segment of the medical profession.
35 PA. CONS. STAT. ANN. § 780-111(d) (West 2000); accord 28 PA. CODE § 25.52
(2000) (regulations); see also Commonwealth, Dep't of Health v. DeMarco, 416
A.2d 623, 626 (Pa. Commw. Ct. 1980) (explaining that the Controlled Substances
Act prescribes conditions under which drugs may be used by practitioner in his prac-
tice, but does not limit practitioner's right to practice medicine), aff'd, 459 A.2d 756
(Pa. 1983).
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malady other than drug abuse.7' Like controlled substances pre-
scription regulations, they do not apply to syringes, but could be
read as evidence of a public policy limiting physician discretion
in matters of drug abuse.
3. Drug Paraphernalia Law
Forty-nine states and the District of Columbia have para-
phernalia laws. 72 Most of these statutes are based on, and often
virtually identical to, a model drug paraphernalia act drafted by
the U.S. Department of Justice in the late 1970s.73 The typical
statute defines drug paraphernalia generally as all equipment,
products, and materials of any kind which are used, intended for
use, or designed for use, "to manufacture, inject, ingest, inhale,
or otherwise introduce into the human body a controlled sub-
stance in violation of' the state's controlled substances laws.74
71 See, e.g., ALA. CODE § 20-2-54(a)(5) (1997) (allowing physician to pre-
scribe controlled substances in certain enumerated instances but not recognizing drug
addiction as an illness); CAL HEALTH & SAFETY CODE § I 153(a)(2) (West Supp.
2000) (stating that a valid legal prescription may be written for an addict or habitual
controlled substance user as part of an authorized narcotic treatment program); CONN.
GEN. STAT. ANN. § 21a-252(a) (West 1994 & Supp. 2000) (restricting the dispensing
of controlled substances for drug dependence, but allowing the dispensing of take-
home doses of methadone under certain circumstances); HAW. REV. STAT. § 329-
38(e)(3) (Supp. 1999); KAN. ADmN. REGs. § 68-20-18(b)(3); MASS. GEN. LAWS
ANN. ch. 94C, § 19(c) (West 1997); MONT. CODE ANN. § 37-7-401 (1999); N.J.
ADMIN. CODE tit. 8, § 65-7.4(c) (2000) (indicating that a prescription may not be used
for the dispensing of narcotic drugs listed in any schedule for "detoxification" or
"maintenance treatment"); NEv. ADMIN. CODE ch. 453, § 430 (2000); N.Y. COMP.
CODEs R. & REoS. tit. 10, § 80.65 (1999) (excluding specifically prescriptions written
for a controlled substance to an addict for their customary use from the statutory
meaning of a prescription); 35 PA. CONS. STAT. ANN. § 780-113(a)(13) (West 2000);
S.C. CODE ANN. § 44-53-360(h) (Law. Co-op. 1985) (restricting prescriptions of
controlled substances to legitimate medical purposes).
7 See Gostin & Lazzarini, supra note 54, at 615. Alaska is the exception
among the states. The territory of Puerto Rico also lacks a paraphernalia law. The
Virgin Islands, not covered in our study, has a drug paraphernalia and a syringe pre-
scription law. See id.
73 See Annotation, Validity, Under Federal Constitution, of So-Called "Head
Shop" Ordinances or Statutes, Prohibiting Manufacture and Sale of Drug Use Re-
lated Paraphernalia, 69 A.L.R. FED. 15, 20-22 (1984) (reprinting the text of the
Model Drug Paraphernalia Act drafted by the U.S. Department of Justice).
74 NEB. REv. STAT. § 28-441 (1995); accord ARIz. REv. STAT. ANN. § 13-
3415(F)(2)(k-l) (West 1989); COLO. REV. STAT. § 18-18-426(l)(g) (1999); D.C.
CODE ANN. § 33-601(3) (1998); GA. CODE ANN. § 16-13-32.1(a) (1996); OHIO REV.
CODE ANN. § 2925.14(A) (Banks-Baldwin Supp. 2000). But see IND. CODE ANN. §
35-48-4-8.5(d)(2) (West 1998) (exempting from ,the paraphernalia law sellers of
items "historically and customarily used in connection with the... injecting.., of...
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It then provides a list of a dozen or more particular items that
could be drug paraphernalia by way of example. In the majority
of states, this list includes "[h]ypodermic syringes, needles, and
other objects used, intended for use, and designed for use in
parenterally injecting controlled substances into the human
body."75 It is important to note, however, that by this definition,
the status of any item as paraphernalia depends not just on the
characteristics of the item itself, but also the intention or acts of
the defendant. A small glass vial used to store saffron in a spice
store is not drug paraphernalia. The same vial, sold with knowl-
edge to a crack dealer and used in packaging his product, would
be paraphernalia.
The model paraphernalia law was written in broad terms, to
encompass almost any type of item that might be used for drug
abuse. Because of this, both legislators and courts were con-
cerned that they could be construed to apply to innocent trans-
actions, people, or equipment.76 To guide the finder of fact,
paraphernalia statutes often include a list of factors to be taken
into consideration when determining whether an item is drug
paraphernalia or not. The list typically includes:
(a) Statements by an owner or person in control of the
object concerning its use.
(b) Prior convictions, if any, of an owner or person in
control of the object, under any state or federal law re-
lating to any controlled substance.
(c) The proximity of the object, in time and space, to a
direct violation of the uniform controlled substances act.
(d) The proximity of the object to controlled substances.
(e) The existence of any residue of controlled sub-
stances on the object.
lawful substance[s]"); S.C. CODE ANN. § 44-53-391(a) (Law. Co-op. 1985) (making
it unlawful to "possess, sell or deliver, or possess with the intent to deliver, or sell
paraphernalia"). The South Carolina paraphernalia law does not include "injection"
or syringes, and thus does not directly apply to heroin use.
7
, NEB. REv. STAT. § 28-439 (1995).
76 See Ferguson et al., supra note 54, at 48-53 (reviewing legislative history of
Pennsylvania's paraphernalia law).
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(f) Direct or circumstantial evidence of the intent of an
owner or person in control of the object, to deliver it to
a person the owner or person in control of the object
knows, or should reasonably know, intends to use the
object to facilitate a violation of the uniform controlled
substances act. The innocence of an owner or person in
control of the object as to a direct violation of the uni-
form controlled substances act shall not prevent a find-
ing that the object is intended for use as drug parapher-
nalia.
(g) Oral or written instructions provided with the object
concerning its use.
(h) Descriptive materials accompanying the object
which explain or depict its use.
(i) National and local advertising concerning the object's
use.
(j) The manner in which the object is displayed for sale.
(k) Whether the owner or person in control of the object
is a legitimate supplier of similar or related items to the
community, such as a distributor or dealer of tobacco
products.
(1) Direct or circumstantial evidence of the ratio of sales
of the object or objects to the total sales of the business
enterprise.
(m) The existence and scope of legitimate uses for the
object in the community.
(n) Expert testimony concerning the object's use.77
Paraphernalia laws usually create two basic offenses: manu-
facturing or distributing, and possessing. The former is phrased
77 KAN. STAT. ANN. § 654151 (1992); accord CAL. HEALTH & SAFImrY CODE
§ 11014.5(c) (West 1991); FLA. STAT. ANN. § 893.146 (West 2000); 720 ILL. COMP.
STAT. ANN. 600/4 (West Supp. 2000); MONT. CODE ANN. § 45-10-102 (1999); VT.
STAT. ANN. tit. 18, § 4475(b) (Supp. 1999).
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in terms that tend to repeat the scienter element built into the
definition, and make it a crime to:
deliver, possess with intent to deliver, or manufacture
with intent to deliver, drug paraphernalia, knowing, or
under circumstances where one reasonably should
know, that it will be used to... inject,... or otherwise
introduce into the human body a controlled substance or
marijuana in violation of [state controlled substances
laws].78
The enforcement of paraphernalia possession laws is often
regarded as an important contributing cause to unsterile injec-
tion.79 It is typically unlawful, in the words of the model statute:
[T]o use, or to possess with intent to use, drug para-
phernalia to ... introduce into the human body a con-
trolled substance in violation of this Act[;] ... deliver,
possess with intent to deliver, or manufacture with in-
tent to deliver, drug paraphernalia, knowing, or under
circumstances where one reasonably should know, that
it will be used to ... introduce into the human body a
controlled substance .... 80
The severity of the offense varies. In most states, it is a
misdemeanor,8 1 but in a few it is a felony. 2 Anecdotal evidence
78 S.D. CODIFIED LAWS § 22-42A-4 (Michie 1998); accord KY. REV. STAT.
ANN. § 218A.500(3) (Banks-Baldwin 1999); MASS. GEN. LAWS ANN. ch. 94C, §
321(a) (West 1997); N.C. GEN. STAT. § 90-113.23 (1999); N.M. STAT. ANN. § 30-31-
25.1(B) (Michie 1997); Wyo. STAT. ANN. § 35-7-1056 (Michie 1999).79 See Bluthenthal et al., supra note 18, at 12; Lawrence 0. Gostin et al., Pre-
vention of HIVAIDS and Other Blood-Borne Diseases Among Injection Drug Users:
A National Suney on the Regulation of Syringes and Needles, 277 JAMA 53 (1997)
(concluding that the strict enforcement of drug paraphernalia laws has greatly con-
tributed to the spread of HIVIAIDS); see also Gostin & Lazzarini, supra note 54, at
648 (noting that restricting access to syringes may contribute to blood-borne infection
in IDUs. their sexual and needle-sharing partners, and their children).
"0 Annotation, Validiv, Under Federal Constitution of So-Called "Head
Shop" Ordinances, supra note 73, at 21.
81 See, e.g., ALA. CODE § 13A-12-260(d)(1) (1994); CAL. HEALTH & SAFETY
CODE § 11374 (West 1991); IND. CODE ANN. § 35-50-3-2 (West 1993); KAN. STAT.
ANN. § 65-4162(a) (Supp. 1999); NEB. REV. STAT. § 28-442 (1995).8 2 See, e.g., ARIz. REV. STAT. ANN. § 13-3415 (West Supp. 1999); HAw. REv.
STAT. § 329-43.5 (1993); IDAHO CODE § 37-2734B (1994); Mo. ANN. STAT. §
195.235 (West 1996); NEV. REV. STAT. ANN. § 453.560 (Michie 1996); S.D.
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and some research suggests that these laws are often enforced,
at least in some statesY
While 49 states have some form of paraphernalia law, they
can differ in small ways that can have significant impact on the
analysis of syringe access by prescription. Nine states' para-
phernalia laws exclude syringes categorically 84 or when sold in
designated amounts.8 5 Six more states provide some kind of
immunity to pharmacists that would cover the filling of a valid
syringe prescription. 86 South Carolina's paraphernalia law omits
any reference to syringes or injection, and does not apply to
items used in the consumption of opiates.
4. Syringe Prescription Law
Thirteen states have a law or regulation that requires a pre-
scription to purchase a syringe under at least some circum-
stances.87 These laws may be divided for present purposes into
two groups: those that pervasively regulate the sale and posses-
sion of needles and constitute a major barrier to IDU access,
and those that do not. The latter group includes three states
CODIFIED LAWS §§ 22-42A-4 & 22-6-1 (Michie 1998); TENN. CODE ANN. § 39-17-
425(b)(2) (1997).
83 See generally Josiah D. Rich et al., The Economic Cost of Strict Syringe
Control, 81 MED. & HEALTHIR.I. 207 (1998) (finding 731 arrests in Rhode Island
between 1994 and 1996, leading to $4.1 million in incarceration costs).
84 Georgia, Oregon, Rhode Island, and Wisconsin. See GA. CODE ANN. § 16-
13-32(c) (1996) (permitting a legitimate medical purpose affirmative defense for
syringes); OR. REv. STAT. § 475.525(3) (1999) ("ldlrug paraphernalia does not in-
clude hypodermic syringes or needles"); R.I. GEN. LAWS § 21-28.5-1(11) (1989)
(excluding "hypodermic syringes, needles, and other objects intended for use or de-
signed for use in parenterally injecting controlled substances into the human body");
Wis. STAT. ANN. § 961.571(1)(b) (West 1998) ("[d]rug paraphernalia" excludes:
"[h]ypodermic syringes, needles and other objects used or intended for use in paren-
terally injecting substances into the human body").
8 Maine, Minnesota, New Hampshire, and New York exclude ten or fewer
syringes. See ME. REv. STAT. ANN. tit. 17-A, § 1110 (West Supp. 1999); MINN.
STAT. ANN. § 151.40 (West 1998); N.H. REV. STAT. ANN. §§ 318:52-c, 52-d, 52-e
(1995 & Supp. 2000); N.Y. PuB. HEALTH LAW § 3381(1)(c) (McKinney 2000) (ef-
fective Jan. 1, 2001). Connecticut's paraphernalia law excludes syringes in amounts
of thirty or fewer. See CONN. GEN. STAT. ANN. § 21a-240(20)(A) (West Supp. 2000).
86 Colorado, Indiana, Louisiana, Montana, Ohio, and Tennessee. See COLO.
REv. STAT. § 18-18-308(6) (1999); IND. CODE ANN. § 25-26-13-16 (West 1998); LA.
REv. STAT. ANN. § 40:1034 (West 1992); MONT. CODE ANN. § 45-10-107 (1999);
OHIO REv. CODE ANN. § 2925.14(D) (Banks-Baldwin Supp. 2000); TENN. CODE
ANN. § 39-17-425(a)(1) (1997).
87 Rhode Island has repealed its syringe prescription law as of September 1,
2000.
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whose laws apply in only limited circumstances (Florida,88 Ne-
vada,89 and Virginia90 ) as well as four states that have "deregu-
lated" sales of ten syringes and fewer (these states - Connecti-
cut, New Hampshire, New York, and Maine - are discussed
below.) This leaves six states (California, Delaware, Illinois,
Massachusetts, New Jersey, Pennsylvania) whose syringe pre-
scription rules remain an impediment to syringe access.
Most of the general prescription laws on the books today
limit who may legally possess a syringe, require a prescription
for sale to non-medical or other unauthorized personnel, and set
out more or less onerous record-keeping requirements. For ex-
ample, Massachusetts' law states:
(a) No person, not being a physician,... registered un-
der the laws of this commonwealth, or of the state
where he resides, or a registered embalmer, manu-
facturer of or dealer in embalming supplies, phar-
macist, wholesale druggist, manufacturing pharma-
cist, manufacturer of or dealer in surgical supplies,
... or a person who has received a prescription is-
sued under subsection (c),... shall have in his pos-
session a hypodermic syringe, hypodermic needle,
or any instrument adapted for the administration of
controlled substances by injection.
(b) No such syringe, needle or instrument shall be de-
livered or sold to, or exchanged with, any person
except a pharmacist,... physician,.... or a person
who has received a written prescription issued un-
der subsection (c) ...
See FLA. STAT. ANN. § 893.147(3)(b) (West 2000) (requiring prescription
only for buyers under 18 years of age), anendedby2000 Fla. Sess. Law Serv. 00-360
(West) (adding "transportation" to section heading restricting the use, possession,
delivery, or advertisement of drug paraphernalia).
Nevada's prescription law allows syringes to be sold without a prescription,
including:
(a) For the use in the treatment of persons having asthma or diabetes.
(b) For use in injecting intramuscular or subcutaneous medications pre-
scribed by a practitioner for the treatment of human beings.
NEv. REV. STAT. ANN. § 454.480(2) (Michie 1996). The effect of these exceptions
has been to allow routine pharmacy sales.
90 See VA. CODE A.N. § 54.1-3468 (Michle 1998) (requiring prescription only
for people sixteen and younger).
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(c) A physician may issue to a patient under his imme-
diate charge a written prescription to purchase, or
may issue an oral prescription to a pharmacist on
behalf of said patient to purchase, from a pharma-
cist only, any of the instruments specified in sub-
section (a). Such prescription shall contain the
name and address of the patient, the description of
the instrument prescribed and the number of in-
struments prescribed. The pharmacist filling the
prescription shall record upon the face of said pre-
scription, over the signature of the pharmacist
making the sale, the date of such sale. Such pre-
scription may be renewed or refilled for one year
unless the physician indicates otherwise on the pre-
scription, and each refilling shall be noted upon the
prescription. No prescription for such instruments
shall be refilled after one year from date of issue.
The pharmacist filling the prescription shall dis-
pense any such instrument in a sanitary container
which shall completely enclose such instrument,
and shall affix to said container a label bearing (1)
the name and address of the pharmacy, and if said
pharmacy is in a hospital, the name and address of
said hospital, (2) the name and address of the pa-
tient, (3) the file number of the prescription, and (4)
the name of the physician prescribing the same. The
person to whom the prescription is issued shall keep
such instrument in said container at all times, ex-
cept when such instrument is in actual use or is in
the process of being cleaned.
(d) A record shall be kept by the person selling such
syringes, needles or instruments, which shall give
the date of the sale, the name and address of the
purchaser and a description of the instrument. This
record shall be open to inspection pursuant to a ju-
dicial warrant or to the provisions of section thirty
[administrative inspection of controlled premises].
(e) No person except . . . a pharmacist or wholesale
druggist, which pharmacist or wholesale druggist is
licensed under the provisions of chapter one hun-
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dred and twelve [Registration of Certain Profes-
sions and Occupations], shall sell, offer for sale,
deliver, or have in possession with intent to sell hy-
podermic syringes, hypodermic needles or any in-
strument adapted for the administration of con-
trolled substances by injection, unless licensed so to
do by the department .... No person except a per-
son listed in subsections (b) or (c) shall obtain, re-
ceive or purchase a hypodermic syringe, hypoder-
mic needle or any instrument adapted for the ad-
ministration of controlled substances by injection,
unless licensed so to do by the department, or by a
local board of health.91
These statutes are strict in the sense that they limit the abil-
ity of individuals to acquire, and pharmacists to sell, syringes.
For present purposes, however, it is to be noted that most state
prescription laws do not purport to set any substantive standard
by way of limiting the physician's discretion to write the sy-
ringe prescription. This can be seen in the one state whose rule
proves the exception. Delaware's law requires that the prescrip-
tion certify that the "possession of such instrument is necessary
for the treatment of an injury, deformity or disease then suffered
by the person possessing the same."
92
5. "Deregulation States"
Eight states and territories may be said to have deregulated
the sale or possession of syringes; i.e., more or less completely
eliminated legal restrictions on the sale and possession of at
least some number of syringes.9 3 Three states (Oregon, Rhode
Island, and Wisconsin) have explicitly excluded syringes from
the definition of "drug paraphernalia" and do not require a pre-
scription or other evidence of medical need to purchase a sy-
ringe. Five states (Connecticut, Maine, Minnesota, New Hamp-
9' MASs. GEN. LAWS ANN. ch. 94C, § 27(a)-(e) (West 1997); accord NEV.
REV. STAT. ANN. § 454.480(1) (Michie 1996).
42 DEL. CODE ANN. tit. 16, § 4757(c) (1995). Based on this provision alone,
we concluded that a Delaware physician may not legally write a prescription for sy-
ringes to an IDU with no other qualifying medical condition.
9. For a detailed analysis on syringe deregulation, see ABA AIDS COOR-
DINATING COMM., DEREGULATION OF HYPODERMIc NEEDLES AND SYRINGES AS A
PUBLIC HEALTH MEASURE: A REPORT ON EMERGING POLICY AND LAW IN THE UNITED
STATES (forthcoming 2001).
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shire, and New York) have changed paraphernalia and/or sy-
ringe prescription laws to remove restrictions on purchase or
possession of ten and fewer needles. Alaska and Puerto Rico
never had statewide paraphernalia or prescription laws, though
Alaska does have ordinances in some cities that restrict syringe
access.
6. The Impact of Needle Exchange Laws
A number of states have passed legislation authorizing nee-
dle exchange programs.94 Generally, such legislation is not di-
rectly relevant to physician prescription and pharmacy sale of
prescribed syringes, both because the statutes specifically
authorize exchange and because exchange is usually carried out
by people who cannot prescribe because they are not licensed.
However, there are exceptions. We found some cases in which
the passage of a needle exchange law was relevant to interpret-
ing the intended coverage of the paraphernalia or prescription
laws, and in at least three states, we concluded that a program of
physician prescription might qualify as a needle exchange pro-
gram as defined in those states' law.95
9 These include: California, Connecticut, District of Columbia, Hawaii,
Maine, Maryland, Massachusetts, New Mexico, Rhode Island, and Vermont.
95 California, District of Columbia, and Vermont. See CAL. HEALTH &
SAFEIY CODE § 11364.7 (West Supp. 2000) (stating that "[n]o public entity, its
agents, or employees shall be subject to criminal prosecution for distribution of hy-
podermic needles or syringes to participants in clean needle and syringe exchange
projects authorized by the public entity pursuant to a declaration of a local emergency
due to the existence of a critical local public health crisis"); D.C. CODE ANN. § 33-
603.1 (1998); VT. STAT. ANN. tit. 18, § 4475(a)(1) (Supp. 1999); see also Project on
Harm Reduction, supra note 52 (referencing syringe and prescription laws for all
states).
In Vermont, for example, a licensed health care provider may apply to the
commissioner of health for authorization to operate a needle exchange program. A
physician and pharmacist could design a program of prescription-based distribution
and submit it for approval under the terms of the state's needle exchange rules, which
would require that the program provide needles free of charge, and offer various re-
ferral services. See Vermont Dept. of Health, Operating Guidelines for Organized
Community-Based Needle Exchange Programs (Sept. 1999) (on file with author).
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B. Analysis of the Physician's Ability to Write a
Syringe Prescription
1. Authority to Prescribe
The first question is whether any laws directly addressing
syringe prescription or the prescription of devices are applica-
ble, as these would be expected to control. In fact, in nearly all
the prescription law states, the prescription law itself did not set
any substantive standard for the prescribing physician, but
rather simply set a6prescription as the sine qua non for dispens-
ing or possession.9 Only Pennsylvania had a statute that set out
96 The two exceptions were Delaware, see supra note 92, and Ohio. In Ohio,
the syringe prescription law, in relevant part, limits provision and possession of sy-
ringes to individuals who have "legal... medicinal purposes." OHIo REV. CODE
ANN. § 3719.172(A)(5) (West 1998 & Supp. 2000). The syringe law on its face re-
peatedly conditions legal possession on a proper purpose or legitimate reason for
possession, making clear that illegal or improper uses will not be tolerated. Allowing
a disease prevention purpose to justify syringe possession that would otherwise be
illegal departs from a maximally stringent interpretation of drug control laws. One
could reasonably read the syringe law to exclude possession in all instances in which
an illegal purpose is present.
This statutory scheme was, however, in place before the medical necessity for
sterile injection equipment arose, so it cannot be said that the legislature intended to
prohibit therapeutic and preventive uses of needles by drug abusers. Unlike most
other states, Ohio's scheme has long carved out a protected zone of discretion for
physicians and other health care providers, and has placed a steep burden on the state
to prove that this discretion was being abused. See State v. Pawlyszyn, 619 N.E.2d
1255, 1258 (Ohio C.P., Cuyahoga County 1993) (finding no clear and convincing
evidence that physician's conduct fell below acceptable standards of medical prac-
tice). In so doing, the legislature recognized that actions that might be illegal when
performed by lay people for non-medical reasons could fall within the proper and
legal exercise of medicine. Just as a physician may sometimes prescribe narcotics to
an actual or possible abuser when the physician believes the drug is medically neces-
sary for purposes other than continuing the patient's addiction, see generally Christo-
pher Vaeth, Annotation, State Law Criminal Liability of Licensed Physician for Pre-
scribing or Dispensing Drug or Similar Controlled Substance, 13 A.L.R.5TH 1, 20
(1993) (controlled substances laws "almost universally . . . contain exceptions in
favor of physicians who, in good faith and in the regular and legitimate practice of
their profession .... prescribe ... narcotics to their patients or to addicts for purposes
of treatment"), so the legislative scheme for injection equipment can reasonably be
read to give physicians the discretion to prescribe needles as a disease prevention
measure even when the patient has other, illegal purposes as well. The 1998 amend-
ment of § 3719.172 to eliminate the requirement that "the pharmacist... shall re-
quire positive identification of each person to whom hypodermics are furnished, and
shall keep a written record of each transaction" indicates a legislative intention to
ease access to syringes. Omo REv. CODEANN. § 3719.172 (West 1998), amended by
Ohio RFv. CODE ANN. § 3719.172 (West Supp. 2000).
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a standard for the prescription of devices generally, which
would presumably include syringes.
In most syringe prescription and non-prescription states,
then, we were left without explicit guidance on the authority of
physicians to prescribe syringes. We did not conclude, however,
that there were no standards. Rather, we examined state law for
the most analogous and sensible standard, which we found al-
most uniformly in controlled substances laws and less clearly,
but still frequently, in general professional standards. We found
the standard there, for the simple reason that the only case law
on prescribing arose out of allegations that the broad, inherent
power to prescribe had been in some way abused. The most
common type of abuse was the prescription of controlled sub-
stances without proper justification or in an improper manner. A
few cases involved allegations, often related to controlled sub-
stance law violations, that prescriptions had been unprofes-
sional. Under the laws of all the states, we expect a court or
medical licensing board would accept a prescription as valid if
it is written in good faith, for a legitimate medical purpose, in
the normal course of professional practice.97 The case law does
not always treat these three prongs separately, and there can
fairly be said to be considerable overlap among them.
A rule allowing possession, and therefore prescription and dispensing, of
needles where there is a legal purpose, even in the presence of a secondary, illegal
purpose, protects physician discretion to make difficult treatment decisions for IDU
patients. It is also more lenient than the contrary rule, and it is a well-settled proposi-
tion that penal laws are to be strictly construed against the state. See State v. Hill, 635
N.E.2d 1248, 1253 (Ohio 1994); State v. Hooper, 386 N.E.2d 1348, 1350 (Ohio
1979). Had the legislature wished to preclude possession with a legal medicinal pur-
pose when there was also an illegal purpose, it could have written the law to say so,
simply by requiring that the possession be "solely" for a legal medicinal purpose.
Based on these considerations, we concluded that physicians had a reasonable claim
to legality in prescribing syringes to injection drug users in Ohio.
9 See, e.g., 21 U.S.C.A. § 802(21) (West 1999) (defining "practitioner" as
able to prescribe a controlled substance in normal course of professional practice); 21
C.F.R. § 1306.04(a) (2000) (stating that prescriptions should be issued only for a
legitimate medical purpose); CAL. HEALTH & SAET CODE § 11210 (West 2000): 35
PA. CONS. STAT. ANN. § 780-111 (d) (West 2000). See also Davis v. Board of Med.
Exam'rs, 239 P.2d 78, 81 (Ca. Dist. CL App. 1951) (detailing physician's claim that
prescription was furnished in good faith and in the regular practice of his profession);
In re DiLeo, 661 So.2d 162, 164-65, 168 (La. Ct. App. 1995); State v. Vaccaro, 361
A.2d 47, 50 (N.J. Super. Ct. App. Div. 1976); Commonwealth v. Larsen, 682 A.2d
783, 787 (Pa. Super. Ct. 1996) (requiring the prescribing of drugs to be performed in
"good faith" by practitioner).
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In normal usage, "good faith" entails a genuine concern for
the well-being of the patient and others who might be infected
through sharing injection equipment with the patient, and con-
duct devoid of malice or deception: "[a] doctor who prescribes a
potentially dangerous drug without first making some attempt to
determine the physical condition or health needs of the person
for whom he writes the prescription is not acting in good faith
and in the usual course of his practice."98 A physician who is
providing syringes to a patient who the physician has deter-
mined cannot or will not enter drug treatment, and whose injec-
tion drug use places him at high risk of contracting or spreading
a communicable disease, should have no difficulty satisfying
the "good faith" prong of the prescription standard.
In determining whether a prescription arises out of the
usual course of professional practice, a court will consider
whether a bona fide doctor-patient relationship existed, whether
other care was provided, whether proper records were kept of
the encounter, and whether the prescription was based on a
proper history or individualized assessment of the patient's risk
factors, efforts to provide other harm reducing services, follow
up and so on. "The phrases 'usual course of business or prac-
tice' of such persons as physicians and surgeons.., are in such
common use that any reasonable man can determine their
meaning. Surely, one licensed as a physician knows when he is
acting in the usual course of his practice of medicine."9 9 In the
leading case, United States v. Moore, the court wrote:
The evidence presented at trial was sufficient for the
jury to find that respondent's conduct exceeded the
bounds of "professional practice."... [H]e gave inade-
quate physical examinations or none at all. He ignored
the results of the tests he did make . . . . He did not
regulate the dosage at all, prescribing as much and as
frequently as the patient demanded. He did not charge
for medical services rendered, but graduated his fee ac-
9" State v. Kane, 586 S.W.2d 812, 814 (Mo. CL App. 1979). See also People
v. Lonergan, 267 Cal. Rptr. 887, 892 (Cal. Ct. App. 1990) (describing good faith as
"that state of mind denoting honesty of purpose, freedom from intention to defraud,
and, generally speaking, means being faithful to one's duty or obligation") (quoting
People v. Nunn, 46 CaI.2d 460, 468 (1956)); Vaccaro, 361 A.2d at 50. "A physician
who is honest and ethical, and dispenses the prohibited drugs in a good faith effort to
treat and cure patients, has no fear of the criminal sanctions of the statute." Id.
99 State v. Bridges, 398 S.W.2d 1, 4 (Mo. 1966).
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cording to the number of tablets desired. In practical ef-
fect, he acted as a large-scale "pusher" - not as a physi-
cian.1 °
A physician prescribing syringes to bona fide patients in his
regular office or in a clinic, keeping records, and providing
other treatment services, would not be at risk of failing this
prong of the test.
Few decisions have clarified the meaning of a "legitimate
medical purpose." Such case law as there is suggests a standard
looking to whether or not other physicians would regard the
practice as legitimate.101 A practice is not illegitimate simply
because some physicians disagree with the practice at issue, but
only where no responsible segment of the medical profession
accepts the appellant's methods.) 2 Expert testimony and at-
tending circumstances will then help the fact-finder determine
the legitimacy of the physician's actions.103
"00423 U.S. 122, 142-43 (1975).
1o1 See, e.g., Commonwealth v. Possinger, 399 A.2d 1077, 1081 (Pa. Super.
Ct. 1979) (recognizing physician's ability to choose between available options of
treatment based on medical judgment); Commonwealth v. Salameh, 617 A.2d 1314,
1316 (Pa. Super. Ct. 1992), appeal denied, 639 A.2d 26 (Pa. 1994) (holding that for a
practitioner to be convicted, it must be shown that no other segment of the medical
profession would have approved the practitioner's choice of treatment).
102 See Glover v. Board of Med. Quality Assurance, 282 Cal. Rptr. 137, 140
(Cal. Ct. App. 1991). "As long as the differences of opinion are legitimate, we have
no dispute with the notion that different methods of treatment can all be considered
acceptable medical practice." ld.; accord Lonergan, 267 Cal.Rptr. at 893. "The fact
that a Physician might have ... acted in a fashion different from that of other practi-
tioners is immaterial if the Physician acted in good faith." Id.
It is often the burden of the physician to prove a legitimate medical purpose.
See Kane, 586 S.W.2d at 814 (holding that physician has the burden of bringing him-
self within the exceptions to a controlled substance statute); accord State v. West,
929 S.W.2d 239 (Mo. Ct. App. 1996). "Generally, where an exception is part of the
section which defines the offense, the burden is on the State to plead and prove that
the defendant is not within the exception. However, where the exception is found in a
separate clause or part of the statute disconnected from the definition of the offense,
the exception is not for the prosecution to negate, but for the defendant to claim as a
matter of affirmative defense." Id. at 242.; see also Mo. ANN. STAT. § 195.180 (West
1996) (indicating that a physician may have burden to prove legitimate reason for
prescribing controlled substance).
103 Significantly, a physician is not limited to only presenting expert medical
witnesses to support the legitimacy of prescribing syringes to IDUs to prevent the
spread of HIV. Missouri courts have shown a willingness to consider the testimony of
any witness whose area of expertise is relevant to the issue at hand. Therefore, a phy-
sician would be able to offer testimony from researchers, syringe exchange programs
[Vol. I 1:5
2001] HARM REDUCTION IN THE HEALTH CARE SYSTEM 43
Medical evidence and public health guidelines, combined
with the support of major professional organizations, make a
compelling case for the practitioner prescribing injection
equipment to IDUs. t°4 Not all physicians will agree that pre-
participants, and others familiar with the beneficial aspects of this practice. See St.
Luke's Hosp. v. May, 588 S.W.2d 217,222 (Mo. Ct. App. 1979).
"'4 See Zita Lazzarini, An Analysis of Ethical Issues in Prescribing and Dis-
pensing Syringes to Injection Drug Users, 11 HEALTH MATRIX 85 (2001); Josiah D.
Rich et al., The Genesis of Syringe Prescription to Prevent HIV in Rhode Island, I 1
HEALTH MATRLX 129 (2001).
In two states, however, the leading cases leave some room for doubt as to the
proper interpretation of the third prong of the standard. The controlled substances
law in Kansas requires only a "medical purpose," and does not use the common
modifier "legitimate." In State v. Vakas, the trial court had dismissed an indictment
against a doctor because the prosecutors had added "legitimate" to the charge. 744
P.2d 812 (Kan. 1987). The Kansas Supreme Court reversed, on the ground that "[ilt
would indeed be a strained construction of the statute to say that the legislature in-
tended the prescription of a controlled substance for an illegitimate purpose to be
lawful and within the statutory exception. Such a determination of legislative intent
and construction of the statute would be ridiculous." Id. at 815. The court also ad-
dressed the meaning of "legitimate:" "The word 'legitimate' when used as a descrip-
tive term is a word of common usage and understanding. Legitimate, when used as it
was here, has been defined as '[r]eal, valid or genuine.' It is also defined as 'lawful,
legal, recognized by law, or according to law.' BLACK'S LAW DICTIONARY 811 (5th
ed. 1979)." Id. In this passage, the court may be understood as departing from the
usual view that the legitimacy of the purpose is to be judged exclusively in medical
terms. On this view, a prescription would only be legitimate if its purpose was both
medically valid as judged by scientific evidence and professional standards, and le-
gally valid (i.e., not in violation of other law.). Given the existence of a paraphernalia
law in Kansas, this is a potentially important distinction.
The most cautious view is that Kansas' paraphernalia statute applies to sy-
ringes prescribed for disease prevention purposes when they will be used to inject
illegal drugs. General medical practice law, on this reading, allows a physician to
write a prescription with a valid medical purpose and, in the course of medical prac-
tice, except when the practitioner knows or should have known the patient intends to
use the item for drug use, when the drug paraphernalia provision makes the purpose
illegitimate. This reading is consistent with the plain meaning of the Kansas para-
phernalia statute, which prohibits any person, without exception for health care pro-
viders, from delivering or causing to be delivered drug paraphernalia to someone
knowing it will be used to ingest illegal drugs. Under this interpretation of "legitimate
medical purpose," a physician in Kansas probably cannot legally prescribe injection
equipment to an IDU patient even as a means of preventing the transmission of seri-
ous blood-borne disease.
Unlike most states, Oklahoma has a definition of "medical purpose" in its
controlled substances law. This definition embraces the use of a controlled substance
for "physical or mental treatment, for diagnosis, or for the prevention of a disease
condition not in violation of any state or federal law and not for the purpose of satis-
fying physiological or psychological dependence or other abuse:" OKLA. STAT. ANN.
tit. 63, § 2-101(24) (Supp. 2000). Inartfully drafted, this provision presents some
difficulty in interpretation. As applied to controlled substances, it appears simply to
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scribing injection equipment is within the bounds of good medi-
cal practice, but only the support of a responsible segment of
medical opinion is required. t5
Despite the widespread perception to the contrary, courts
are quite reluctant to interfere with physician discretion in the
practice of medicine.10 6 Courts have consistently held that pre-
scribing statutes were not meant to "invade the legitimate doc-
tor-patient relationship when the doctor may dispense or pre-
scribe... for medical reasons."' 0 7 Providing injection equipment
to drug-injecting patients out of a sincere desire to prevent dis-
ease transmission, without pecuniary motive, clearly satisfies
the prescription standard. Given this medical evidence, it would
also be difficult to argue that providing sterile injection equip-
ment falls beneath the minimal standards of professional prac-
tice set forth in the laws governing the practice of medicine.
2. Limits on Physician Prescribing Authority
We turn now to the second question: Do any other laws
prohibit physicians from prescribing sterile injection equipment
to IDU patients? We generally identified two main possibilities.
Some states have provisions that explicitly prohibit a phy-
sician from prescribing controlled substances to a known drug
dependent person for the purpose of maintaining their addic-
restate the proviso that satisfying or maintaining an illegal drug habit is not a valid
medical purpose. If generalized to the analogous case of syringe prescription, how-
ever, it could well be read to refer to the paraphernalia law, which forbids syringe
delivery or possession for drug use purposes. On this view, a physician may prescribe
a drug or device to prevent a disease unless in so doing he or the patient would vio-
late some other law. In this instance, that law would be the paraphernalia statute,
which generally prohibits delivery or possession of a syringe knowing that it will be
used for illegal drug injection. We conclude that an Oklahoma physician would have
a reasonable claim to legality in prescribing a syringe for the purpose of preventing a
blood-borne disease, but we cannot conclude that it is clearly legal to do so.
105 See Glover, 282 Cal. Rptr. at 140; see also Stephen E. Stone, The Investi-
gation and Prosecution of Professional Practice Cases Under the Controlled Sub-
stances Act: Introduction to Professional Practice Case Law and Investigations, 10
DRUG ENFORCEMENT 21, 23-26 (1983).
'06 See Marshall B. Kapp, Treating Medical Charts Near the End of Life: How
Legal Anxieties Inhibit Good Patient Deaths, 28 U. TOL L. REv. 521 (1997) (de-
scribing the interaction between physicians, law, policy, and the courts).
107 United States v. Collier, 478 F.2d 268, 274 (5h" Cir. 1973). See also United
States v. Lindler, 268 U.S. 5, 15, 18 (1925) (holding that the meaning of legitimate
medical practice depends on the facts and circumstances of each case).
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tion.108 Such statutes could be the basis of an argument that pro-
viding sterile injection equipment must also be illegal. Per this
argument, providing syringes enables drug users to maintain
their drug use, and is therefore inconsistent with the basic pur-
poses of the law.
This argument has a common-sense appeal, but should fail
on at least two grounds. First, the plain language of the prohibi-
tion does not embrace syringes, and it is a cardinal rule of
statutory construction in most states that criminal laws are to be
strictly construed against the state.10 9 Under this rule, a court
should not read a criminal statute as prohibiting conduct it does
not explicitly prohibit. Second, even if we accept the analogy
between providing controlled substances and providing sterile
equipment for injecting them, the provisions themselves not un-
commonly make an exception for prescriptions necessary to
treat some other malady.l1u Preventing the spread of infectious
disease, while not literally curing or treating a disease, is a
plainly acceptable medical intervention, and so would seem to
fall well within a broad interpretation of the provision.
Drug paraphernalia laws were a more serious possibility,
which we addressed in a narrow, technical fashion. The ultimate
issue presented by this mode of needle distribution is whether
the prescription is sufficient basis for the legal sale of the sy-
ringe by the pharmacist. This issue nearly always turned on the
proper interpretation of the scope and application of a parapher-
nalia law. For physicians, however, a plain-text reading of the
paraphernalia laws has generally led along a narrower path to
the non-applicability of paraphernalia laws.
Nearly all paraphernalia laws characterize the criminal act
as to "deliver, possess with intent to deliver or manufacture
with the intent to deliver drug paraphernalia with knowledge, or
under circumstances where one reasonably should know, that it
108 See. e.g., CAL HEALTH & SAFETY CODE § 11156 (West 1991) (stating that
"[nJo person shall prescribe for or administer, or dispose a controlled substance to an
addict or habitual user, or to any person representing himself as such, except as per-
mitted by this division").
09 See, e.g., State v. Barnes, 859 P.2d 1387, 1388 (Idaho 1993) (citing State
v. Sivak, 806 P.2d 413, 418 (Idaho 1990)); State v. Dougherty, 216 S.W.2d 467, 471
(Mo. 1949).
"' See, e.g., Mo. ANN. STAT. § 334.106(4) (West Supp. 2000) (stating that a
physician is not liable for or accountable to the board for prescribing addictive or
potentially addictive medications or treatments).
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will be used to . . .inject,... or otherwise introduce into the
human body a controlled substance" in violation of the act."'1
The definition of "delivery" usually comes from the defini-
tions section of the state controlled substances act, and takes
this form: "the actual, constructive, or attempted transfer from
one person to another of a controlled substance, whether or not
there is an agency relationship."'1 2 A physician who writes a
prescription for an item is not actually transferring possession
of that item to the patient, but merely providing the patient with
instructions and authorization for the pharmacist who will trans-
fer possession by dispensing the prescription.
Nor does the concept of a constructive delivery embrace the
writing of a prescription. Constructive delivery requires, at a
minimum, prior constructive possession of the item. One con-
structively possesses a controlled substance "when one knows
of the nature or character of the substance and of its presence
and has dominion or control over it."113 The authority to write a
prescription for a syringe does not give the physician the ability
to exercise dominion over it; like the patient, he would have to
go to the pharmacy and purchase the syringe in order to possess
it, and so cannot be said to constructively possess it.114 Since the
.. N.M. STAT. ANN. § 30-31-25.1(B) (Michie 1997) (emphasis added); ac-
cordALA. CODE § 13A-12-260(d)(1) (1994).
112 IOWA CODE ANN. § 124.101 (West Supp. 2000). See also CONN. GEN.
STAT. ANN. § 21a-240(I I) (West 1994).
11 State v. DeGroat, 508 N.W.2d 861, 865 (Neb. 1993) (citations omitted).
See, e.g., State v. Jeffries, 858 S.W.2d 821 (Mo. Ct. App. 1993) (holding that con-
structive possession of controlled substances requires evidence that defendant had
access to and control over premises where controlled substance was found); State v.
Janson, 964 S.W.2d 552 (Mo. Ct. App. 1998) (finding constructive possession if facts
exist that demonstrate defendant had knowledge of the presence of a controlled sub-
stance).
114 It should be noted that courts interpreting controlled substances laws have
sometimes interpreted terms like "sell," "dispense," "furnish" or "distribute" to em-
brace the writing of a prescription for a controlled substance. See, e.g., Jin Fuey Moy
v. United States, 254 U.S. 189, 192-94 (1920) (affirming defendant's conviction for
unlawfully issuing a prescription in violation of the Anti-Narcotic Act); United States
v. Thompson, 624 F.2d 740 (5th Cir. 1980) (affirming conviction of physician for
unlawfully dispensing a controlled substance); Commonwealth v. Comins. 356
N.E.2d 241, 244 (Mass. 1976), cert. denied, 430 U.S. 946 (1977); State v. Moody,
393 So.2d 1212, 1214-15 (La. 1981) (detailing requirements to convict a physician
for unlawful distribution of a prescription drug). See generally Vaeth, supra note 96,
at 20 (enumerating and clarifying elements of possession). In our state-by-state
analyses of case law, however, we did not generally find these interpretations of con-
trolled substances acts to be applicable to the rather different terminology used in
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physician does not have any level of possession of the syringe,
he can not logically be capable of delivering it.
Our legal analysis revealed that only a handful of state laws
set out explicit criteria to govern a physician's prescription of
injection equipment. We found that prescribing injection
equipment in good faith, in the course of a physician's normal
professional practice, and for a legitimate medical purpose, like
disease prevention, was legal in 48 states and territories. Writ-
ing a prescription for a syringe probably violates laws in Dela-
ware and Kansas, and presents a reasonable claim to legality in
Ohio and Oklahoma.
V. MAY A PHARMACIST LEGALLY FELL SUCH A
PRESCRIPTION?
Writing the prescription is only an effective health inter-
vention if the patient can then purchase the syringes at a phar-
macy. Our research found that pharmacists were clearly or ar-
guably subject to more restrictions than physicians, leading to
the finding that filling a valid syringe prescription for a known
IDU is clearly legal in 26 states, with a reasonable claim to le-
gality in 22 more. (See Table II.)
A. The Regulatory Environment
1. Pharmacy Licensure Law
All states regulate the practice of pharmacy."15 The regula-
tory structure typically includes a statute setting out basic re-
drg paraphernalia laws. See, e.g., Project on Harm Reduction, supra note 52, Mas-
sachusetts Memorandum.
Additionally, there is little risk that prescribing a syringe could be prosecuted
as aiding and abetting a violation of the paraphernalia statute that would occur when
the pharmacist dispensed the syringe, or for conspiracy to violate the paraphernalia
statute. Although this charge is available to a motivated prosecutor, such a prosecu-
tion would be unusual: we found no reported case in any state of a charge of aiding
and abetting a paraphernalia violation. More importantly, the crime depends upon the
underlying illegality of providing sterile injection equipment by prescription. Our
analysis suggests that this behavior is not a crime in most states. With a valid pre-
scription, a patient is not violating the paraphernalia law when he purchases the nee-
dle, and the physician, or pharmacist, cannot be his accomplice or co-conspirator.
"-" See e.g., ALAsKA STAT. §§ 08.80.003-.08.80.105 (Michie 1998); CONN.
GEN. STAT. ANN. §§ 20-570-20-630 (West 1999); IDAHO CODE § 54-1702 (1994),
LA. REv. STAT. ANN. § 37:1171-1214 (West 1988); Omo REv. CODE ANN. §§
4729.01-4729.99 (West 1998 & Supp. 2000).
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quirements for licensure and standards of professional prac-
tice." 6 These requirements are administered by state pharmacy
boards, which have authority to promulgate further regulations
and the responsibility to enforce practice rules through discipli-
nary action. 117 Pharmacists who fail to maintain the required
standards are subject to discipline up to and including revoca-
tion of their license." 8 Syringe prescription and record-keeping
laws or regulations, discussed below, are often codified within
pharmacy law. 19
Pharmacy practice laws set out basic standards of profes-
sional practice, usually in the form of a list of acts that consti-
tute "unprofessional conduct." These lists identify specific ille-
gal practices. The disciplinary provisions of Arkansas' Phar-
macy Act provide one example:
The Arkansas State Board of Pharmacy may revoke an
existing license of a licensed pharmacist or may suspend
the license or may refuse to issue a license if the holder
or applicant, as the case may be, has committed or is
found guilty by the board of any of the following acts or
offenses set forth: ...
(3) That the person has been found guilty or pleaded
guilty or nolo contendere in a criminal proceeding, re-
gardless of whether or not the adjudication of guilt or
sentence is withheld, by a court of this state, another
state, or the federal government for:
(A) Any felony;
116 See, e.g., CONN. GN. STAT. ANN. §§ 20-576-20-639 (West 1999); W. VA.
CODE §§ 30-5-1-30-5-24 (1998); 201 Ky. ADMN. REGS. 2:010-2:240 (2000); OKLA.
ADMIN. CODE §§ 535:10-3-1.1-535:10-7-8 (2000).
17 See, e.g., ARK. CODE ANN. § 17-92-311 (Michie 1995); COLO. REv. STAT.
§ 12-22-108 (1999); 225 ILL. COMP. STAT. ANN. 85/11 (West 1998); N.H. REV. STAT.
ANN. § 318:5-a (1995); N.Y. EDUC. LAW § 6804 (McKinney 1985).
"' See, e.g., FLA. STAT. ANN. § 465.016(2) (West Supp. 2000); VT. STAT.
ANN. tit. 26, § 2032(b)(2) (1998).
"9 See, e.g., CAL. Bus. & PROF. CODE §§ 4141-42 (West 2000) (prohibiting
the furnishing of syringes without a board license and the selling of syringes without
a prescription).
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(B) Any act involving moral turpitude, gross immoral-
ity, or which is related to the qualifications, functions,
and duties of a licensee; or
(C) Any violation of the pharmacy or drug laws of this
state or rules and regulations pertaining thereto, or of
the pharmacy or drug statutes, rules, and regulations of
any other state or of the federal government; ...
(7) That the person has been guilty of gross unprofes-
sional or dishonorable conduct;
(8) That the person has willfully violated any of the
provisions of the pharmacy laws of the State of Arkan-
sas;12
0
A pharmacist is generally authorized to dispense medica-
tions ordered by a valid prescription, and is ordinarily expected
to do so in the absence of a good reason to refuse.12' At the
same time, a pharmacist is not required to blindly follow a
practitioner's orders. New Jersey's pharmacy regulations state
that:
The pharmacist shall have the right to refuse to fill a
prescription if, in his or her professional judgment, the
prescription is outside the scope of practice of the pre-
scriber; or if the pharmacist has sufficient reason to
question the validity of the prescription; or to protect
the health and welfare of the patient.
120 ARK. CODE ANN. § 17-92-311(a)(1-8) (Michie 1995). See also D.C. CODE
ANN. § 2-2010 (1994) (stating conditions under which the mayor can withhold, sus-
pend, or withdraw a pharmacist's license); see also LA. REV. STAT. ANN. § 37:1225
(West 1988) (determining that the standards of pharmacy arise under the disciplinary
provisions of the pharmacy act within a section on the code of ethics).
121 See STEvEN STRAUSS, THE PHARMACIST AND THE LAW 29-31 (1980)
(summarizing duty of pharmacist to prescribe drugs that are to be administered in the
patient's best interest); see also Steven W. Huang, The Omnibus Reconciliation Act
of 1990: Redefining Pharmacists' Legal Responsibilities, 24 AM. J.L. & MED. 417,
421-37 (1998).
122 N.J. ADMIN. CODE tit. 13, § 13:39-6.1(a) (2000). The regulations for the
controlled substance law in most states make clear that a pharmacist has an inde-
pendent responsibility to ensure that controlled substances are properly prescribed.
See also Askin v. Commonwealth Dep't of Pub. Welfare, 423 A.2d 1371, 1373-74
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A "right" and perhaps a common-law duty to exercise some dis-
cretion is, in a few states, stated as a positive requirement. For
example, Colorado's licensure law prohibits the filling of pre-
scriptions in the absence of medical need:
Medical need: No licensee or registrant shall compound,
dispense, deliver or distribute any drug to any person in
such quantity or in any situation where the licensee or
registrant knows or reasonably should know said drug
has no recognized medical utility or application. Viola-
tion of this rule shall constitute prima facie proof of
violation of CRS 12-22-125. 12
2. Syringe Specific Laws
Pharmacy law nationally includes four basic types of con-
trols over syringe sales: the requirement of a prescription,
24
which often most directly applies to pharmacists; "sub-
prescription" requirements, such as requiring the buyer to dem-
onstrate a legitimate medical or legal purpose for the syringe
purpose;'1 record-keeping and display laws; 2 6 and, finally, a
(Pa. Commw. Ct. 1981). The Pennsylvania court followed the language of 28 PA.
CODE § 25.52(a) (1995) which presently states that "ft]he responsibility for proper
prescribing of controlled substances is upon the practitioner but a corresponding re-
sponsibility rests with the pharmacist who dispenses the medication and interprets the
directions of the prescriber to the patient." In other states, the standard for filling a
prescription is governed by the pharmacist's usual course of practice.
123 3 CoLO. CODE REGS. § 719-3.00.20 (1999).
124 See discussion supra Part IV.A(4).
125 See e.g., GA. CODE AN. § 16-13-41(f)(3) (1996) (requiring legitimate
medical purpose).
1 6The Pharmacy Act in Indiana, for example, sets forth identification and
record-keeping requirements that limit the sale of syringes and needles:
(a) A... device known as a hypodermic syringe and/or needle for human
use may be dispensed by a pharmacist without a prescription to a purchaser
at retail, provided that: ...
(4) the pharmacist requires every purchaser of a... device ... not known
to the pharmacist to furnish suitable identification (including proof of age
where appropriate); and
(5) separate bound record books for dispensing of... devices under this
section...
are maintained by the pharmacist. These books shall contain the name and
address of the purchaser, the name and quantity of... devices purchased,
the date of each purchase, and the name or initials of the pharmacist who
dispensed the substance or devices to the purchaser these books shall be
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variety of informational and disposal rules that are found pri-
marily in states that have liberalized or deregulated syringe pur-
chase limits. 27
3. Controlled Substances and Drug Paraphernalia Laws
The controlled substances and paraphernalia laws discussed
earlier in connection with prescribing 128 are also applicable to
analyzing the legality of filling syringe prescriptions for IDU
patients,
B. Analysis of the Pharmacist's Ability to Dispense a Syringe
We have concluded above that a physician's prescription
for sterile injection equipment, written under the factual condi-
tions assumed for purposes of this analysis, is valid under law
in 48 jurisdictions. Ordinarily, the pharmacist is required to fill
a valid prescription. 129 In the several states that do not have
paraphernalia laws, syringe prescription statutes or syringe-
related pharmacy regulations, this is the end of the analysis.'
30
In the five states allowing the sale of syringes in amounts of ten
and under, a pharmacist may likewise dispense up to ten sy-
ringes without a prescription. 13' In the remaining states, the
maintained in accordance with the recordkeeping requirements of 856 IAC
2-4-1 ....
IND. ADMIN. CODE tit. 856, r. 2-6-18(a) (2000). See also N.Y. PuB. HEALTH LAW §
3381 (McKinney 1993 & Supp. 2000).127 See, e.g., MINN. STAT. ANN. § 151.40 (West 1998) (requiring a pharmanist
to properly dispose of used hypodermic needles and syringes).128 See discussion supra Part IV.A.2 & Part IV.A.3.
129 A pharmacist presumably could refuse to fill a syringe prescription if he
believed that the prescription was unlawful, potentially harmful to ultimate user, or
was not for a legitimate medical reason. See, e.g., ALA. ADmIN. CODE r. 680-X-2-
.21(2) (2000); 3 COLO. CODE REGS. §§ 719-3.00.20; 719-3.00.50 (1999); N.Y. COMP.
CODES R. & REGS. Lit. 10, § 80.65 (holding pharmacist ultimately responsible for
filling a prescription of a controlled substance for an addict to support his his/her
habit).
"o These states include Alaska and Puerto Rico, which have no paraphernalia
statutes, and Oregon, Wisconsin, and Rhode Island, which have deregulated syringe
sales for disease prevention purposes.
1-"' Connecticut (see CONN. GEN. STAT. ANN. § 21a-65 (West 1994 & Supp.
2000) (exempting general restrictions upon the sale of hypodermic needles for state
exchange programs)), Maine (see ME. REv. STAT. ANN. tit. 17-A, § 1110 (west
Supp. 1999), Minnesota (see MINN. STAT. ANN. § 151A0 (West 1998)), New Hamp-
shire (see N.H. REv. STAT. ANN. § 318:52-c (1995 & Supp. 2000) (effective Jan. 1,
2001, the prescription law excludes less than 11 syringes for adults and the parapher-
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question is whether filling the prescription would be prohibited
under any other provision of law. Our state-by-state research
found that the paraphernalia law was the key factor proscribing
the dispensing of a syringe.
There are four states in which some specific element of law
makes dispensing clearly illegal, including the two states in
which prescribing is clearly illegal in the first place. In Kansas,
case law narrowly interprets "medical purpose" to mean both a
medically valid and legally valid purpose.132 Similarly, dis-
pensing in Georgia is clearly illegal because of its pharmacy
regulations, which require syringes to be sold only for a "law-
ful" purpose. Delaware limits syringe sale and possession to the
"treatment of a . . . disease then suffered," and Hawaii law
makes clear that syringes distributed for disease prevention are
one of the enumerated items covered by the paraphernalia law.
The remaining states can be divided into three groups: (1)
states with a paraphernalia law that clearly does not limit sy-
ringe access; (2) states with both a paraphernalia and a pre-
scription law, the interaction of which determines legality; and
(3) the remaining states, where the legality of dispensing a pre-
scribed syringe turns on whether the paraphernalia law was in-
tended to reach the sale of syringes, by prescription, for a le-
gitimate medical reason. An analysis of each of these categories
follows.
1. Paraphernalia Laws Not Applicable
Leaving aside the states that have deliberately deregulated
syringe access for health purposes, there are seven states whose
paraphernalia laws, for one reason or another, do not apply to
either pharmacists or syringes. 33 (See Table II.) The parapher-
nalia statutes in Indiana and South Carolina omit needles and
"injecting" from the list of uses that make an item drug para-
phernalia. Four other states (Colorado, Montana, Tennessee and
West Virginia) have pharmacy and paraphernalia laws that pro-
vide immunity or exemption for pharmacists who fill valid pre-
nalia law does not apply to injection equipment)), and New York (effective Jan. 1,
2001, excludes prescriptions limited to ten or fewer hypodermic needles or syringes,
see N.Y. PuB. HEALTH LAW § 3381(1)(c) (MeKinney 2000)).
132See State v. Vakas, 744 P.2d 812, 814-15 (Kan. 1987).
133 Colorado, Indiana, Louisiana, Montana, South Carolina, Tennessee, and
West Virginia. See supra Table II.
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scriptions. Louisiana also carves out an exemption in its para-
phernalia law for bona fide medical use:
It shall be an affirmative defense that the person to
whom the drug related object or advertisement or notice
was distributed had a prescription from a licensed medi-
cal practitioner or psychiatrist for marijuana or the con-
trolled substance for which the object is primarily in-
tended to be used.134
In Ohio and Iowa, state paraphernalia laws may reasonably
be interpreted to exclude from liability a pharmacist who dis-
penses medications ordered by a valid prescription. Ohio ex-
empts pharmacists and physicians from paraphernalia law, but
restricts syringe distribution via its specific syringe prescription
law. Iowa excludes syringes distributed for a "lawful purpose"
from its paraphernalia statute. 3 '
It is also important to note that virtually all paraphernalia
laws are triggered by the seller's knowledge of the illegal use.
Our analysis and categorizations in Table I assume the phar-
macist knows or has reason to know that the syringe will be
used for illicit drug use. In fact, however, it is very likely that in
a significant proportion of cases, the pharmacist will not know
the purchaser's intent to inject illegal drugs. Moreover, these
laws impose no affirmative obligation to inquire. In all such
cases, filling the prescription for the IDU does not violate the
paraphernalia law.
2. Prescription Law States
In eight states (New Jersey, California, Delaware, 136 illi-
nois, Massachusetts, Nevada, Pennsylvania, Virginia), our
-' LA. REV. STAT. ANN. § 40:1034(B) (West 1992). For a detailed discussion
of other paraphernalia laws, see Project on Harm Reduction, supra note 52, for state-
by-state memoranda.
"a For a detailed analysis of the Iowa paraphernalia statute, see Project on
Harm Reduction, supra note 52.
136 As mentioned above, Delaware's prescription law limits syringe posses-
sion to those for whom it is "necessary for the treatment of an injury, deformity or
disease then suffered." DEL CODE ANN. tit. 16, § 4757(c) (1995). The purpose of
prescribing a syringe is to prevent disease transmission or acquisition. It does not
"treat" the disease in the common sense of the word. However, it could be argued
that syringe prescription "treats" the disease of drug addiction by reducing the harm
caused by the condition. See Project on Harm Reduction, supra note 52, Delaware
Memorandum.
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analysis found that the specific prescription laws applied more
readily to syringe dispensing than the broadly phrased para-
phernalia statutes. The prescription laws generally require a
prescription, but do not set out substantive criteria for when a
prescription is valid (see discussion above.) In most of the pre-
scription law states, the prescription and paraphernalia laws do
not refer to each other, but exist side by side in a way that
would create inconsistent results if they were read to apply to
pharmacists filling valid prescriptions. In these states, we read
the syringe prescription laws to supersede and displace para-
phernalia laws.
Generally, when two statutes overlap to create apparently
inconsistent requirements, the more specific statute controls.".7
The hypodermic possession and sale laws are the more specific
provisions. These provisions focus exclusively upon hypoder-
mic syringes and needles, while the paraphernalia laws usually
address the full range of items that might be used in connection
with drug consumption, preparation or sale. Massachusetts'
paraphernalia law, for example, applies to "any person" and
covers:
[A~lI equipment, products, devices and materials of any
kind which are primarily intended or designed for use in
planting, propagating, cultivating, growing, harvesting,
manufacturing, compounding, converting, producing,
processing, preparing, testing, analyzing, packaging, re-
packaging, storing, containing, concealing, injecting,
ingesting, inhaling or otherwise introducing into the
human body a controlled substance in violation of this
chapter.138
137 See CAL. CIV. PRO. CODE § 1859 (West 2000): "In the construction of a
statute the intention of the Legislature ... is to be pursued, if possible; and when a
general and [a] particular provision are inconsistent, the latter is paramount to the
former. So a particular intent will control a general one that is inconsistent with it."
See generally 2B NORMAN J. SINGER, STATUTES AND STATUTORY CONSTRUCTION
(SUTHERLAND STATUTORY CONSTRUCTION) § 46.06 (6th ed. 2000) (discussing that
each word of a statute is to be given effect).
138 MASS. GEN. LAWS ANN. ch. 94C, § 1(d) (West Supp. 2000). Application of
the paraphernalia law to "any person" appears in MASS. GEN. LAws ANN. ch. 94C, §
321 (West 1997).
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In contrast, Massachusetts' syringe prescription law focuses on
regulating sale, control/possession, and prescription of hypo-
dermic syringes by pharmacists, physicians and patients:
(a) No person, not being a physician .... registered un-
der the laws of this commonwealth, or of the state
where he resides, or a registered embalmer, manu-
facturer of or dealer in embalming supplies, phar-
macist, wholesale druggist, manufacturing pharma-
cist, manufacturer of or dealer in surgical supplies,
... or a person who has received a prescription issued
under subsection (c) .... shall have in his possession
a hypodermic syringe, hypodermic needle, or any
instrument adapted for the administration of con-
trolled substances by injection ....
(c) A physician may issue to a patient under his imme-
diate charge a written prescription to purchase...
from a pharmacist only, any of the instruments
specified in subsection (a) .... The pharmacist fill-
ing the prescription shall record upon the face of
said prescription, over the signature of the pharma-
cist making the sale, the date of such sale. Such pre-
scription may be renewed or refilled for one year
unless the physician indicates otherwise on the pre-
scription, and each refilling shall be noted upon the
prescription. No prescription for such instruments
shall be refilled after one year from date of issue
139
California, Illinois, Nevada, Pennsylvania, and Virginia also
have syringe-specific laws allowing pharmacists to dispense
injection equipment for legitimate purposes. 140 The syringe law
in these states focuses on health care providers and others with
legitimate professional uses for syringes, within the context of
regulating users and suppliers of controlled substances and re-
lated devices. In contrast, the paraphernalia law applies to all
individuals without any exception for physicians and pharma-
cists. Under the traditional canons of statutory construction, the
3  MASS. GEN. LAWS ANN. ch. 94C, § 27(a), (c) (West 1997).
14) See Project on Harm Reduction, supra note 52 (containing syringe and
paraphernalia law analysis for all states).
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narrower and more specific syringe statute would apply to
pharmacists, rather than the broadly phrased paraphernalia law.
In one state, New Jersey, it is quite clear that the legislature
intended to distinguish between syringes and other types of
paraphernalia, and to give physicians and pharmacists a special
role in their distribution and sale. New Jersey's general para-
phernalia statute, N.J. Stat. Ann. §§ 2C:36-1 to -7, makes a
systematic distinction between drug paraphernalia generally and
syringes:
" Section 2C:36-1' 41 is the familiar broad, intent-driven defi-
nition of drug paraphernalia. Notably, however, it excludes
the word "inject" and does not include syringes in the illus-
trative list of items that may be drug paraphernalia under
some circumstances.
" Sections 2C:36-2 42 and 2C:36-3143 prohibit, respectively,
possession and distribution of drug paraphernalia.
141 As used in this act, "drug paraphernalia" means all equipment, products
and materials of any kind which are used or intended for use in planting,
propagating, cultivating, growing, harvesting, manufacturing, compounding,
converting, producing, processing, preparing, testing, analyzing, packaging, re-
packaging, storing, containing, concealing, ingesting, inhaling, or otherwise in-
troducing into the human body a controlled dangerous substance or controlled
substance analog in violation of the provisions of chapter 35 of this title.
N.J. STAT. ANN. § 2C:36-1 (West Supp. 2000).
142 It shall be unlawful for any person to use, or to possess with intent to use,
drug paraphernalia to plant, propagate, cultivate, grow, harvest, manufacture,
compound, convert, produce, process, prepare, test, analyze, pack, repack,
store, contain, conceal, ingest, inhale, or otherwise introduce into the human
body a controlled dangerous substance or controlled substance analog in viola-
tion of the provisions of chapter 35 of this title. Any person who violates this
section is guilty of a disorderly persons offense.
N.J STAT. ANN. § 2C:36-2 (West Supp. 2000).
143 It shall be unlawful for any person to distribute or dispense, or possess with
intent to distribute or dispense, or manufacture with intent to distribute or dis-
pense, drug paraphernalia, knowing that it will be used to plant, propagate, cul-
tivate, grow, harvest, manufacture, compound, convert, produce, process, pre-
pare, test, analyze, pack, repack, store, contain, conceal, ingest, inhale or oth-
erwise introduce into the human body a controlled dangerous substance or
controlled substance analog in violation of the provisions of chapter 35 of this
title. Any person who violates this section commits a crime of the fourth de-
gree.
N.J. STAT. ANN. § 2C:36-3 (West Supp. 2000).
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* Section 2C:36-4144 prohibits advertising of paraphernalia.
Section 2C:36-5145 raises the penalty for those who distrib-
ute to minors.
* Section 2C:36-6146 prohibits possession or distribution of
syringes unless otherwise authorized by law.
* Section 2C:36-7 authorizes forfeiture of "[a]ny drug para-
phernalia, hypodermic syringe or needle seized in violation
of this chapter."'
147
The plain text of New Jersey's paraphernalia statute evinces
and accomplishes the intent to regulate syringes separately from
other items that can be used with illicit drugs, and not to include
syringes in any substantive provision of the statute other than
those in which they are explicitly named. In three separate sec-
tions of the paraphernalia statute, the legislature carefully ex-
cised references to syringes and injection from the model act it
was adopting. In a fourth section, it added specific prohibitions
applicable only to syringes, more stringent than those applied to
drug paraphernalia generally. In a fifth section, it referred to
syringes and needles disjunctively from drug paraphernalia. 48
144 It shall be unlawful for any person to place in any newspaper, magazine,
handbill, or other publication any advertisement, knowing that the purpose of
the advertisement in whole or in part, is to promote the sale of objects intended
for use as drug paraphernalia. Any person who violates this section commits a
crime of the fourth degree.
N.J. STAT. ANN. § 2C:36-4 (West Supp. 2000).
145 Any person 18 years of age or over who violates N.J.S. 2C:36-3 by deliver-
ing drug paraphernalia to a person under 18 years of age commits a crime of
the third degree.
N.J. STAT. ANN. § 2C:36-5 (West Supp. 2000).
146 Except as otherwise authorized by law, it shall be unlawful for a person to
have under his control or possess with intent to use a hypodermic syringe, hy-
podermic needle or any other instrument adapted for the use of a controlled
dangerous substance or a controlled substance analog as defined in chapter 35
of this title or to sell, furnish or give to any person such syringe, needle or in-
strument. Any person who violates this section is guilty of a disorderly persons
offense.
N.J. STAT. ANN. § 2C:36-6 (West Supp. 2000).
147 N.J. STAT. ANN. § 2C:36-7 (West Supp. 2000).
14s This interpretation also adheres to the general rule that "when there is a
conflict between general and specific provisions of a statute, the specific provisions
will control." Wilson v. Unsatisfied Claim & Judgment Fund Bd., 536 A.2d 752,756
(N.J. 1988). In this instance, sections 2C:36-2 and -3 conflict with section -6 not only
in the state of mind required for a violation but on the very question at issue here: the
syringe-specific provision allows any sale of a syringe on valid prescription, even if
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Prosecutions of needle exchange staff for syringe distribu-
tion in prescription law states support the contention that sy-
ringe and paraphernalia statutes operate distinctly from each
other. An established usage in regard to the meaning and effect
of a statute is a relevant and persuasive guide to its authoritative
interpretation. 49 The drug paraphernalia and syringe prosecu-
tions brought by New Jersey's Attorney General have arguably
given rise to an "established usage" of these statutes. Both of
New Jersey's major needle exchange prosecutions, 150 were
brought under section six, the syringe-specific provision, and
not under the general drug paraphernalia prohibition of section
three. Moreover, no pharmacist or pharmacy had been charged
with any sort of paraphernalia violation in the state.1 51 This is
also true of prosecutions in Massachusetts and New York.15
2
the seller knows it will be used for illicit injection. Such a sale would be prohibited
under the general paraphernalia provision.
Interpretation of the paraphernalia act begins with the federal Model Drug
Paraphernalia Act, upon which the New Jersey law was based. A comparison of the
two statutes' definitions of drug paraphernalia provides unmistakable evidence that
the New Jersey legislature intended to exclude syringes from the general category of
drug paraphernalia as defined in the statute. Although the New Jersey Act is virtually
identical to the Model Act, both references to injection equipment in the Model Act
were omitted by the New Jersey legislators who drafted the state provision. The leg-
islature deliberately diverged from the model act in this respect, a decision that makes
perfect sense given a decision to exclude syringes from the general drug parapherna-
lia provisions, and which makes no sense if we assume that the legislature intended to
include syringes within the general definition of drug paraphernalia. It is an accepted
canon of statutory interpretation in New Jersey that "where the Legislature has care-
fully employed a term in one place and excluded it in another, it should not be im-
plied where excluded." GE Solid State, Inc. v. Director, Div. of Taxation, 625 A.2d
468, 473 (N.J. 1993); see also SINGER, supra note 137, at § 47:24 (applying the
maxim of expressio unius to determine the effect of statutory language).
149 See SINGER, supra note 137, at § 49.06.
15 See State v. Sorge, 591 A.2d 1382 (N.J. Supr. Ct. Law Div. 1991) (deny-
ing motion to dismiss prosecution of needle exchange activists); State v. McCague,
714 A.2d 937, 939 (N.J. Super. Ct. App. Div. 1998). Needle exchangers in New York
and Massachusetts have also been prosecuted under syringe laws, not paraphernalia
statutes.
151 In fact, there have been no cases in which a pharmacist or pharmacy had
been charged with any paraphernalia violation in any of the 52 jurisdictions.
152 See Commonwealth v. Leno, 616 N.E.2d 453 (Mass. 1993); People v.
Bordowitz, 588 N.Y.S.2d 507 (N.Y. Crim. Ct. 1991) (finding defendants not guilty
under hypodermic needle possession statute because their conduct met the standards
of the medical necessity).
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3. Paraphernalia Law Only States
The 22 states where syringe dispensing by prescription is
arguably, but not indisputably, legal, generally share in common
the existence of a paraphernalia law and a lack of any law that
explicitly authorizes syringe sales in a pharmacy or that other-
wise renders that paraphernalia law inapplicable. In cases where
a pharmacist dispenses a syringe to an IDU, the pharmacist is
undoubtedly transferring the syringe. Thus, if a syringe is clas-
sified as drug paraphernalia and the pharmacist is aware of the
syringe's intended use, then the transfer is illegal. We thus
come to the fundamental question of whether the sale of a sy-
ringe dispensed by a valid prescription, for legitimate medical
reasons, is prohibited by paraphernalia law.'
55
The most cautious view is that dispensing under these cir-
cumstances would violate state paraphernalia law. The para-
phernalia statutes may be read as a limitation on the practitio-
ner's authority to dispense. General professional practice law,
on this reading, allows a pharmacist to fill a prescription written
with a valid medical purpose and in the course of medical prac-
tice, except when the pharmacist knows or should know the pa-
tient intends to use the item for drug use, when a drug para-
phernalia provision interposes its prohibition. This reading is
consistent with the terms of paraphernalia statutes, which pro-
hibit any person, without exception for health care providers,
from providing drug paraphernalia to someone knowing it will
be used to ingest illegal drugs.
It does not follow, however, that this cautious reading is the
correct reading. It may reasonably be argued that drug para-
phernalia laws do not and were not intended to regulate health
care professionals acting within the scope of their professional
practice, and that both the syringe prescription provisions and
the interpretive guidance included in the statutes provide a clear
basis for excluding syringes sold by prescription for disease
prevention purposes.
15. In many cases, whether something is drug paraphernalia depends, in nar-
rowest terms, upon whether the seller knows or has reason to know that it will be
used for illegal drug use. As stated above, however, a pharmacist who does not know
or have reason to know that the patient intends to use the syringe to inject illegally,
does not violate the paraphernalia law, even if in fact the item will be used for drug
abuse.
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In all states, the object of interpretation and construction of
laws is to ascertain and effectuate the intent of the legislature.
In Illinois, for example, determining what the framers of legis-
lation intended entails first looking "to the words of the statute,
and it is only where the words are inadequate that the court may
turn to legislative history and interpretative aids to discover the
legislative intent."1 56 New Jersey case law further provides that,
"[olur duty is to apply the legislative intent as expressed in the
statute's language, and we are not to presume that the Legisla-
ture intended something other than what it expressed by its
plain language." 157 Thus, a faithful effort to determine legisla-
tive intent should be guided by both the language of the statute
and the expressed purposes of the lawmakers who wrote it, to
avoid absurd results.
There is considerable evidence in the text and background
of typical state paraphernalia law to indicate that it was never
intended to regulate the distribution of medical devices in the
heath care system. As a class, paraphernalia laws were never
aimed at physicians and pharmacists. States began passing
paraphernalia laws in the late 1970s, as part of a national trend
led by the federal government, to eliminate what had become an
enormous retail trade in the equipment necessary to use illegal
drugs. By 1976, between 15,000 and 30,000 "head shops" did
an annual three billion dollar business in such items as rolling
papers, bongs, and freebasing kits.1 58 The statutes apparently
have significantly reduced the number of head shops. There is
no indication in the history of either the model act or any statute
to suggest, however, that it was intended to interfere with good
medical care or public health interventions to prevent disease.
In the only case on point, the court concluded that para-
phernalia laws do not prohibit legitimate public health measures
to increase access to needles. In Spokane County Health District
156 McQueen v. Erickson, 378 N.E.2d 614, 617 (Ill. App. Ct. 1978). See also
Commissioner of Revenue v. Dupee, 670 N.E.2d 173, 176 (Mass. 1996); Renz v.
Penn Cent. Corp., 435 A.2d 540, 542 (N.J. 1981) ("[W]e must first look at the evi-
dent wording of the statute to ascertain its plain meaning and intent"); State Employ-
ees' Ass'n of N.H., Inc. v. Cheney, 409 A.2d 775, 777 (N.H. 1979) (finding that
agency interpretation of statutory language is persuasive authority for judicial inter-
pretation of legislative intent).
157 Toll Bros., Inc. v. West Windsor Twp., 712 A.2d 266, 270 (N.L Super. CL
App. Div. 1998) (emphasis added).
15 See Gostin & Lazzarini, supra note 54, at 611-12 (reviewing Congres-
sional investigation of the paraphernalia problem).
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v. Brockett,159 the Supreme Court of Washington was faced with
the question of whether needle exchange programs operated by
health authorities under their general powers were prohibited by
the Washington drug paraphernalia statute. The Court wrote:
It is undisputed the needles at issue in this case are
"drug paraphernalia". Those distributing the needles
know they will be used to inject controlled substances
unlawfully. Nevertheless, plaintiffs argue, the needle
exchange program is authorized under the Washington
Constitution, statutes granting broad powers to local
health officials, and the omnibus AIDS act. Therefore,
they conclude, the drug paraphernalia act, which is
aimed at criminal conduct, simply does not apply to
their actions. We agree, finding the [Spokane County
Health Department's] needle exchange program permis-
sible under the constitution and statutes of this state. 160
Physicians' and pharmacists' decisions about prescribing or
dispensing medication are controlled by the professional prac-
tice and controlled substances laws, not a paraphernalia law
aimed at commercial drug businesses. Indeed, were the drug
paraphernalia law to apply to legitimate disease prevention ac-
tivities, it would be illegal to even provide DUs with bleach for
sterilizing needles or alcohol pads for disinfecting an injection
site. 16' Yet, these are universally accepted measures, which have
never been subject to prosecution. Prosecutions and convictions
under paraphernalia law have been consistent with this latter
interpretation: all the reported cases under the law involve head
shops or individuals also convicted of possession and/or distri-
bution of controlled substances. 62
The foregoing analysis makes clear that a pervasive web of
laws, administrative regulations, and practice guidelines define
the circumstances under which injection equipment may be sold
'" 839 P.2d 324 (Wash. 1992).
160 Brockett, 839 P.2d at 328.
,61 See id. at 328-29.
162 See, e.g., Florida Businessmen for Free Enter. v. City of Hollywood, 673
F.2d 1213 (1Ilth Cir. 1982) (upholding constitutionality of headshop laws restricting
advertisements); Subuh v. State, 732 So.2d 40 (Fla. Dist. Ct. App. 1999) (finding
prosecution failed to prove defendant's knowledge that glass pipes are used to ingest
illegal drugs).
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or dispensed. Syringe-specific laws do not usually pose a barrier
to pharmacy dispensing of syringes. Most prescription law
states require just that-a prescription-and no more. While
paraphernalia laws are inapplicable to pharmacists and syringes
in a number of states, drug paraphernalia statutes remain the
greatest source of uncertainty for the 22 states categorized as
having a "reasonable claim to legality."
VI. HOW MIGHT LAWS BE CHANGED OR
CLARIFIED TO PROMOTE ACCESS TO STERILE
INJECTION EQUIPMENT FOR IDUS THROUGH
THE HEALTH CARE SYSTEM?
In the first thorough analysis of the legality of prescribing
and dispensing syringes through the health care system, we
found that both prescribing and dispensing sterile injection
equipment is legal in most states. Public health, medical, and
legal organizations have all supported increased access to sterile
syringes in order to combat the infectious disease epidemic
among IDUs. However, to adequately increase syringe avail-
ability to IDUs, immediate action must be taken by both state
governments and health care practitioners.
It is not possible to optimally facilitate safe injecting with-
out removing the legal barriers that have limited it. Where ap-
plicable, state legislatures should therefore repeal prescription
and paraphernalia laws to legalize the over-the-counter sale of
injection equipment under all circumstances. Syringe possession
should also be decriminalized to permit IDUs to obtain syringes
from reliable sources like physicians, pharmacists, public health
officials, and registered syringe exchange programs. All the
available evidence suggests that these steps would reduce dis-
ease without increasing drug use.
In the absence of deregulation, state medical and pharmacy
boards can facilitate syringe prescription under current law.
These boards have the power to and should issue regulations
explicitly stating that providing sterile injection equipment to
IDU patients in order to prevent transmission of serious com-
municable disease is an acceptable medical/pharmacy practice.
The Pharmacy Board in Washington has taken such action by
interpreting the term "legal purpose" to include disease preven-
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tion. 163 Medical and pharmacy boards could also require train-
ing in the theory and practice of harm reduction as part of man-
dated continuing education. Instructing health care profession-
als about infectious disease and the unique needs of IDUs
would enable them to make informed decisions about the pre-
scription and sale of syringes.
Physicians and pharmacists can play a critical role to in-
crease access to sterile injection equipment. Where legality is
clear, physicians and pharmacists should strongly consider pre-
scription distribution of syringes as a legitimate clinical inter-
vention to prevent infectious disease transmission. In cases
where legality is less clear, professionals faced with uncertainty
about the applicable law may be unwilling to run the legal risk.
This need not lead to inaction, however. Avenues exist for clari-
fying the law and minimizing the risks of criminal liability or
professional sanction. 164 Discussions with public health agen-
cies, professional boards, and colleagues will be useful in test-
ing the local acceptance of the medical necessity of providing
sterile syringes and needles to injection drug users. Contact with
law enforcement officials can do a great deal to clarify both the
interpretation of the law and the willingness of authorities to
prosecute. Physicians and pharmacists may be able to seek fur-
" ' The board's draft resolution, which has been approved in principle by the
medical board, states:
Whereas: Recent studies by the Centers for Disease Control and Preven-
tion (CDC) and by various states have found that a large number of new
cases of HIV/AIDS, hepatitis and other sexually transmitted diseases are
found in persons who either are injection drug users [(IDU's)] or who have
had sexual relationships with IDU's. A recent meeting cosponsored by
CDC, National Association of Boards of Pharmacy, and the American
Pharmaceutical Association demonstrated that revisions in state laws [and]
rules to permit the unrestricted sale or distribution of sterile needles and sy-
ringes would reduce the transmission of blood-borne diseases.
"Now Therefore be it Resolved: that the Washington State Board of
Pharmacy has determined that the term, "legal use" as used in 70.115.050
RCW - Hypodermic Syringes includes, the distribution of sterile hypo-
dermic syringes and needles for the purpose of reducing the transmission
of blood-borne diseases:' [Such distribution shall be performed through
public health and community based HIV prevention programs.]
Meeting Minutes, Washington State Bd. of Pharmacy, Distribution of Needles
and Syringes to Prevent the Transmission of Communicable Diseases, Apr. 7,
1999. available at <http:lwww.doh.wa.govlpharmacylbdmtgs.htm#ninutes>;
see also WASH REv. CODE ANN. § 70.115.050 (West 2000).
'4 See Burnis et al., supra note 54, at 1164-65.
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ther guidance in the form of an opinion from the state attorney
general, 165 or go to court for a declaratory judgment. 16
It is within the power and the obligation of state govern-
ments and the medical profession to help insure that the law
does not prohibit care that is medically legitimate. In the few
states where paraphernalia laws or pharmacy regulations appear
to categorically prohibit the dispensing of syringes, physicians
and pharmacists may add their considerable professional weight
to efforts to change these rules. It is clear that only a thorough
revision of drug policy will adequately address the health care
needs of injection drug users. However, physicians and pharma-
cists can offer a new approach to disease prevention among
IDUs-one that can begin with one prescription.
165 In most states, state agencies and/or individual practitioners may request
an opinion of the attorney general on the proper interpretation of a statute. See e.g.,
CONN. GEm. STAT. ANN. § 4-176 (West 1998); N.H. REv. STAT. ANN. § 7:7 (1988);
N.J. STAT. ANN. § 52:17A-4 (West 1986 & Supp. 2000). However, as a general rule,
Attorney General opinions are considered persuasive authority, and are not binding.
166 Declaratory judgments are available to individuals whose contemplated
conduct could subject them to criminal prosecution. A brief review of case law indi-
cates that physicians or health care organizations that wish to prescribe injection
equipment to IDU patients would have standing, along with dispensing pharmacists,
to sue a county prosecutor charged with the duty of enforcing the criminal law. See
e.g., Lucky Calendar Co. v. Cohen, 117 A.2d 487, 492 (N.J. 1955); Keuper v. Wil-
son, 268 A.2d 760,762 (N.J. Super. Ct. Ch. Div. 1970); see also Griffith v. Board of
Med. Exam'rs, 454 So.2d 683 (Fla. Dist. CL App. 1984) (allowing practitioners to
seek declaratory statement by their respective agencies).
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